0001438423
--12-31
2024
Q2
false
Yes
Yes
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0001438423
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001438423
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001438423
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001438423
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001438423
us-gaap:RetainedEarningsMember
2024-06-30
0001438423
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001438423
us-gaap:RetainedEarningsMember
2024-03-31
0001438423
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001438423
2024-03-31
0001438423
us-gaap:RetainedEarningsMember
2023-12-31
0001438423
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001438423
us-gaap:RetainedEarningsMember
2023-06-30
0001438423
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001438423
us-gaap:RetainedEarningsMember
2023-03-31
0001438423
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001438423
2023-03-31
0001438423
us-gaap:RetainedEarningsMember
2022-12-31
0001438423
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001438423
us-gaap:CommonStockMember
2024-06-30
0001438423
us-gaap:CommonStockMember
2024-03-31
0001438423
us-gaap:CommonStockMember
2023-12-31
0001438423
us-gaap:CommonStockMember
2023-06-30
0001438423
us-gaap:CommonStockMember
2023-03-31
0001438423
us-gaap:CommonStockMember
2022-12-31
0001438423
2023-01-01
2023-12-31
0001438423
mram:TwoThousandSixteenEmployeeStockPurchasePlanMember
2024-03-31
0001438423
us-gaap:RestrictedStockUnitsRSUMember
2024-06-30
0001438423
us-gaap:RestrictedStockUnitsRSUMember
2023-12-31
0001438423
us-gaap:RestrictedStockUnitsRSUMember
2024-01-01
2024-06-30
0001438423
us-gaap:SellingAndMarketingExpenseMember
2024-04-01
2024-06-30
0001438423
us-gaap:ResearchAndDevelopmentExpenseMember
2024-04-01
2024-06-30
0001438423
us-gaap:GeneralAndAdministrativeExpenseMember
2024-04-01
2024-06-30
0001438423
us-gaap:SellingAndMarketingExpenseMember
2024-01-01
2024-06-30
0001438423
us-gaap:ResearchAndDevelopmentExpenseMember
2024-01-01
2024-06-30
0001438423
us-gaap:GeneralAndAdministrativeExpenseMember
2024-01-01
2024-06-30
0001438423
us-gaap:SellingAndMarketingExpenseMember
2023-04-01
2023-06-30
0001438423
us-gaap:ResearchAndDevelopmentExpenseMember
2023-04-01
2023-06-30
0001438423
us-gaap:GeneralAndAdministrativeExpenseMember
2023-04-01
2023-06-30
0001438423
us-gaap:SellingAndMarketingExpenseMember
2023-01-01
2023-06-30
0001438423
us-gaap:ResearchAndDevelopmentExpenseMember
2023-01-01
2023-06-30
0001438423
us-gaap:GeneralAndAdministrativeExpenseMember
2023-01-01
2023-06-30
0001438423
mram:RadHardProduct1AgreementMember
2024-06-30
0001438423
us-gaap:TransferredOverTimeMember
2024-04-01
2024-06-30
0001438423
us-gaap:TransferredAtPointInTimeMember
2024-04-01
2024-06-30
0001438423
us-gaap:SalesChannelThroughIntermediaryMember
2024-04-01
2024-06-30
0001438423
us-gaap:SalesChannelDirectlyToConsumerMember
2024-04-01
2024-06-30
0001438423
us-gaap:RoyaltyMember
2024-04-01
2024-06-30
0001438423
us-gaap:ProductAndServiceOtherMember
2024-04-01
2024-06-30
0001438423
us-gaap:LicenseMember
2024-04-01
2024-06-30
0001438423
us-gaap:EMEAMember
2024-04-01
2024-06-30
0001438423
srt:NorthAmericaMember
2024-04-01
2024-06-30
0001438423
srt:AsiaPacificMember
2024-04-01
2024-06-30
0001438423
mram:RadHardProduct1AgreementMember
2024-04-01
2024-06-30
0001438423
us-gaap:TransferredOverTimeMember
2024-01-01
2024-06-30
0001438423
us-gaap:TransferredAtPointInTimeMember
2024-01-01
2024-06-30
0001438423
us-gaap:SalesChannelThroughIntermediaryMember
2024-01-01
2024-06-30
0001438423
us-gaap:SalesChannelDirectlyToConsumerMember
2024-01-01
2024-06-30
0001438423
us-gaap:RoyaltyMember
2024-01-01
2024-06-30
0001438423
us-gaap:ProductAndServiceOtherMember
2024-01-01
2024-06-30
0001438423
us-gaap:LicenseMember
2024-01-01
2024-06-30
0001438423
us-gaap:EMEAMember
2024-01-01
2024-06-30
0001438423
srt:NorthAmericaMember
2024-01-01
2024-06-30
0001438423
srt:AsiaPacificMember
2024-01-01
2024-06-30
0001438423
mram:RadHardProduct1AgreementMember
2024-01-01
2024-06-30
0001438423
us-gaap:TransferredOverTimeMember
2023-04-01
2023-06-30
0001438423
us-gaap:TransferredAtPointInTimeMember
2023-04-01
2023-06-30
0001438423
us-gaap:SalesChannelThroughIntermediaryMember
2023-04-01
2023-06-30
0001438423
us-gaap:SalesChannelDirectlyToConsumerMember
2023-04-01
2023-06-30
0001438423
us-gaap:RoyaltyMember
2023-04-01
2023-06-30
0001438423
us-gaap:ProductAndServiceOtherMember
2023-04-01
2023-06-30
0001438423
us-gaap:LicenseMember
2023-04-01
2023-06-30
0001438423
us-gaap:EMEAMember
2023-04-01
2023-06-30
0001438423
srt:NorthAmericaMember
2023-04-01
2023-06-30
0001438423
srt:AsiaPacificMember
2023-04-01
2023-06-30
0001438423
us-gaap:TransferredOverTimeMember
2023-01-01
2023-06-30
0001438423
us-gaap:TransferredAtPointInTimeMember
2023-01-01
2023-06-30
0001438423
us-gaap:SalesChannelThroughIntermediaryMember
2023-01-01
2023-06-30
0001438423
us-gaap:SalesChannelDirectlyToConsumerMember
2023-01-01
2023-06-30
0001438423
us-gaap:RoyaltyMember
2023-01-01
2023-06-30
0001438423
us-gaap:ProductAndServiceOtherMember
2023-01-01
2023-06-30
0001438423
us-gaap:LicenseMember
2023-01-01
2023-06-30
0001438423
us-gaap:EMEAMember
2023-01-01
2023-06-30
0001438423
srt:NorthAmericaMember
2023-01-01
2023-06-30
0001438423
srt:AsiaPacificMember
2023-01-01
2023-06-30
0001438423
mram:RadHardProduct1AgreementMember
2022-01-01
2024-06-30
0001438423
mram:CreditFacility2019Member
2023-01-01
2023-06-30
0001438423
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001438423
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001438423
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001438423
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001438423
mram:CreditFacility2019Member
2024-06-30
0001438423
us-gaap:EmployeeStockOptionMember
2024-06-30
0001438423
us-gaap:RestrictedStockUnitsRSUMember
mram:TwoThousandSixteenEquityIncentivePlanMember
2024-06-30
0001438423
us-gaap:RestrictedStockUnitsRSUMember
mram:TwoThousandSixteenEquityIncentivePlanMember
2024-01-01
2024-06-30
0001438423
us-gaap:EmployeeStockOptionMember
2024-01-01
2024-06-30
0001438423
us-gaap:ProductMember
2024-04-01
2024-06-30
0001438423
mram:LicensingRoyaltyAndOtherRevenuesCustomersMember
2024-04-01
2024-06-30
0001438423
us-gaap:ProductMember
2024-01-01
2024-06-30
0001438423
mram:LicensingRoyaltyAndOtherRevenuesCustomersMember
2024-01-01
2024-06-30
0001438423
us-gaap:ProductMember
2023-04-01
2023-06-30
0001438423
mram:LicensingRoyaltyAndOtherRevenuesCustomersMember
2023-04-01
2023-06-30
0001438423
us-gaap:ProductMember
2023-01-01
2023-06-30
0001438423
mram:LicensingRoyaltyAndOtherRevenuesCustomersMember
2023-01-01
2023-06-30
0001438423
mram:CustomerCMember
srt:MaximumMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-04-01
2024-06-30
0001438423
mram:CustomerBMember
srt:MaximumMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-04-01
2024-06-30
0001438423
mram:CustomerAMember
srt:MaximumMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-04-01
2024-06-30
0001438423
mram:CustomerEMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-04-01
2024-06-30
0001438423
mram:CustomerDMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-04-01
2024-06-30
0001438423
mram:CustomerEMember
srt:MaximumMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerCMember
srt:MaximumMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerBMember
srt:MaximumMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerBMember
srt:MaximumMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerAMember
srt:MaximumMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerAMember
srt:MaximumMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerEMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerDMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerDMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerCMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001438423
mram:CustomerEMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-04-01
2023-06-30
0001438423
mram:CustomerDMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-04-01
2023-06-30
0001438423
mram:CustomerCMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-04-01
2023-06-30
0001438423
mram:CustomerBMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-04-01
2023-06-30
0001438423
mram:CustomerAMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-04-01
2023-06-30
0001438423
mram:CustomerEMember
srt:MaximumMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001438423
mram:CustomerBMember
srt:MaximumMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001438423
mram:CustomerDMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001438423
mram:CustomerCMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001438423
mram:CustomerAMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001438423
mram:CustomerCMember
srt:MaximumMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001438423
mram:CustomerEMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001438423
mram:CustomerDMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001438423
mram:CustomerBMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001438423
mram:CustomerAMember
us-gaap:RevenueFromContractWithCustomerMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001438423
2023-06-30
0001438423
2022-12-31
0001438423
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001438423
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001438423
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001438423
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001438423
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001438423
us-gaap:FairValueMeasurementsRecurringMember
2024-06-30
0001438423
us-gaap:FairValueInputsLevel1Member
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001438423
us-gaap:FairValueMeasurementsRecurringMember
2023-12-31
0001438423
mram:StockOptionsAndRestrictedStockUnitsMember
2024-04-01
2024-06-30
0001438423
mram:StockOptionsAndRestrictedStockUnitsMember
2024-01-01
2024-06-30
0001438423
mram:StockOptionsAndRestrictedStockUnitsMember
2023-04-01
2023-06-30
0001438423
mram:StockOptionsAndRestrictedStockUnitsMember
2023-01-01
2023-06-30
0001438423
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001438423
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001438423
2024-01-01
2024-03-31
0001438423
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001438423
2023-04-01
2023-06-30
0001438423
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001438423
2023-01-01
2023-03-31
0001438423
mram:RadHardProduct1AgreementMember
2022-01-01
2022-12-31
0001438423
mram:TwoThousandSixteenEmployeeStockPurchasePlanMember
2024-01-01
2024-01-31
0001438423
mram:GlobalfoundriesMember
mram:JointDevelopmentAgreementMember
2014-10-17
2014-10-17
0001438423
2023-01-01
2023-06-30
0001438423
2024-06-30
0001438423
2023-12-31
0001438423
2024-04-01
2024-06-30
0001438423
2024-08-01
0001438423
2024-01-01
2024-06-30
xbrli:shares
iso4217:USD
mram:region
iso4217:USD
xbrli:shares
xbrli:pure
Table of Contents
                                 UNITED STATES                                  
                       SECURITIES AND EXCHANGE COMMISSION                       
                             Washington, D.C. 20549                             
                                      FORM                                      
                                      10-Q                                      
(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


                         For the quarterly period ended                         
                                 June 30, 2024                                  
                                                                                
                                       OR                                       
                                                                                

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


                         For the transition period from                         
                                                                                
                                       to                                       
                                                                                
                                                                                
                             Commission File Number                             
                                   001-37900                                    
                          Everspin Technologies, Inc.                           
             (Exact name of Registrant as specified in its Charter)             


                                                      
            Delaware                   26-2640654     
  (State or other jurisdiction      (I.R.S. Employer  
of incorporation or organization)  Identification No.)


                           5670 W. Chandler Boulevard                           
                                       ,                                        
                                   Suite 130                                    
                                    Chandler                                    
                                       ,                                        
                                    Arizona                                     
                                     85226                                      
          (Address of principal executive offices including zip code)           
                                                                                
             Registrant's telephone number, including area code: (              
                                      480                                       
                                       )                                        
                                    347-1111                                    
Securities registered pursuant to Section 12(b) of the Act:

                                                                                           
Title of each class             Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 MRAM              The Nasdaq Stock Market LLC              


Indicate by check mark whether the Registrant: (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
Registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days.
YES


NO


Indicate by check mark whether the Registrant has submitted electronically 
every Interactive Data File required to be submitted pursuant to Rule 405 of 
Regulation S-T ((s)232.405 of this chapter) during the preceding 12 months (or 
for such shorter period that the Registrant was required to submit such files).

YES


NO


Indicate by check mark whether the Registrant is a large accelerated filer, an 
accelerated filer, a non-accelerated filer, a smaller reporting company, or an 
emerging growth company. See the definitions of "large accelerated filer", 
"accelerated filer", "smaller reporting company," and "emerging growth 
company" in Rule 12b-2 of the Exchange Act.

                                                    
Large accelerated filer   Accelerated filer         
Non-accelerated filer     Smaller reporting company 
                                                    
                          Emerging growth company   




                                                                                                                              
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period 
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  


Indicate by check mark whether the Registrant is a shell company (as defined 
in Rule 12b-2 of the Exchange Act).    YES

NO


The number of shares of the Registrant's Common Stock outstanding as of August 
1, 2024, was
21,743,166
.




Table of Contents
                               Table of Contents                                


                                                                                     
                                                                                 Page
                               PART I-FINANCIAL INFORMATION                          
Item 1.   Financial Statements                                                       
          Condensed Balance Sheets as of June 30,                                   3
          2024 (unaudited) and December 31, 2023                                     
          Condensed Statements of Operations and Comprehensive (Loss) Income for    4
          the three and six months ended June 30, 2024 and 2023 (unaudited)          
          Condensed Statements of Stockholders' Equity for the three                5
          and six months ended June 30, 2024 and 2023 (unaudited)                    
          Condensed Statements of Cash Flows for the six                            6
          months ended June 30, 2024 and 2023 (unaudited)                            
          Notes to Condensed Financial                                              7
          Statements (unaudited)                                                     
Item 2.   Management's Discussion and Analysis of                                  15
          Financial Condition and Results of Operations                              
Item 3.   Quantitative and Qualitative                                             23
          Disclosures About Market Risk                                              
Item 4.   Controls and Procedures                                                  23
                                                                                     
                                PART II-OTHER INFORMATION                            
Item 1.   Legal Proceedings                                                        23
Item 1A.  Risk Factors                                                             24
Item 2.   Unregistered Sales of Equity                                             40
          Securities and Use of Proceeds                                             
Item 3.   Defaults Upon Senior Securities                                          40
Item 4.   Mine Safety Disclosures                                                  40
Item 5.   Other Information                                                        40
Item 6.   Exhibits                                                                 41
EXHIBIT INDEX                                                                      41
SIGNATURES                                                                         43


In this Quarterly Report on Form 10-Q, "we," "our," "us," "Everspin 
Technologies," and "the Company" refer to Everspin Technologies, Inc. The 
Everspin logo and other trade names, trademarks or service marks of Everspin 
Technologies are the property of Everspin Technologies, Inc. This report 
contains references to our trademarks and to trademarks belonging to other 
entities. Trade names, trademarks and service marks of other companies 
appearing in this report are the property of their respective holders. We do 
not intend our use or display of other companies' trade names or trademarks to 
imply a relationship with, or endorsement or sponsorship of us by, any other 
companies.

                                       2                                        
Table of Contents
PART I-FINANCIAL INFORMATIO
N
Item 1. Financial Statement
s
                                                                                
                          EVERSPIN TECHNOLOGIES, INC.                           
                            Condensed Balance Sheet                             
                                       s                                        
               (In thousands, except share and per share amounts)               
                                  (Unaudited)                                   


                                                                                                               
                                                                                        June 30,   December 31,
                                                                                         2024         2023     
Assets                                                                                                         
Current assets:                                                                                                
Cash and cash equivalents                                                              $  36,764      $  36,946
Accounts receivable, net                                                                  10,114         11,554
Inventory                                                                                  7,987          8,391
Prepaid expenses and other current assets                                                    517            988
Total current assets                                                                      55,382         57,879
Property and equipment, net                                                                3,790          3,717
Right-of-use assets                                                                        5,182          5,495
Other assets                                                                                 211            212
Total assets                                                                           $  64,565      $  67,303
                                                                                                               
Liabilities and Stockholders' Equity                                                                           
Current liabilities:                                                                                           
Accounts payable                                                                       $   1,950      $   2,916
Accrued liabilities                                                                        1,760          4,336
Deferred revenue                                                                               -            336
Lease liabilities, current portion                                                         1,275          1,190
Total current liabilities                                                                  4,985          8,778
Lease liabilities, net of current portion                                                  3,996          4,390
Long-term income tax liability                                                               162            214
Total liabilities                                                                      $   9,143      $  13,382
Commitments and contingencies (Note 5)                                                                         
Stockholders' equity:                                                                                          
Preferred stock, $                                                                             -              -
0.0001                                                                                                         
par value per share;                                                                                           
5,000,000                                                                                                      
shares authorized;                                                                                             
no                                                                                                             
shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively                          
Common stock, $                                                                                2              2
0.0001                                                                                                         
par value per share;                                                                                           
100,000,000                                                                                                    
shares authorized;                                                                                             
21,656,683                                                                                                     
and                                                                                                            
21,080,472                                                                                                     
shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively                          
Additional paid-in capital                                                               195,774        191,569
Accumulated deficit                                                                            (              (
                                                                                         140,354        137,650
                                                                                               )              )
Total stockholders' equity                                                                55,422         53,921
Total liabilities and stockholders' equity                                             $  64,565      $  67,303
                                                                                                               


   The accompanying notes are an integral part of these condensed financial     
                                  statements.                                   

                                       3                                        
Table of Contents
                          EVERSPIN TECHNOLOGIES, INC.                           
       Condensed Statements of Operations and Comprehensive (Loss) Income       
               (In thousands, except share and per share amounts)               
                                  (Unaudited)                                   


                                                                                                                     
                                                         Three Months Ended June 30,      Six Months Ended June 30,  
                                                           2024              2023           2024            2023     
Product sales                                           $      9,887      $     13,406  $     20,747     $     27,183
Licensing, royalty, patent, and other revenue                    749             2,341         4,319            3,410
Total revenue                                                 10,636            15,747        25,066           30,593
Cost of product sales                                          5,235             6,090        11,238           12,213
Cost of licensing, royalty, patent, and other revenue            185               464           452              757
Total cost of sales                                            5,420             6,554        11,690           12,970
Gross profit                                                   5,216             9,193        13,376           17,623
Operating expenses:                                                                                                  
1                                                                                                                    
Research and development                                       3,457             2,708         6,875            5,907
General and administrative                                     3,254             3,507         7,290            6,727
Sales and marketing                                            1,324             1,355         2,630            2,670
Total operating expenses                                       8,035             7,570        16,795           15,304
(Loss) income from operations                                      (             1,623             (            2,319
                                                               2,819                           3,419                 
                                                                   )                               )                 
Interest expense                                                   -                 -             -                (
                                                                                                                   63
                                                                                                                    )
Other income, net                                                393             2,262           791            2,390
Net (loss) income before income taxes                              (             3,885             (            4,646
                                                               2,426                           2,628                 
                                                                   )                               )                 
Income tax (expense) benefit                                       (                 -             (                -
                                                                  76                              76                 
                                                                   )                               )                 
Net (loss) income and comprehensive (loss) income       $          (      $      3,885  $          (     $      4,646
                                                               2,502                           2,704                 
                                                                   )                               )                 
Net (loss) income per common share:                                                                                  
Basic                                                   $          (      $       0.19  $          (     $       0.23
                                                                0.12                            0.13                 
                                                                   )                               )                 
Diluted                                                 $          (      $       0.18  $          (     $       0.22
                                                                0.12                            0.13                 
                                                                   )                               )                 
Weighted average shares of common stock outstanding:                                                                 
Basic                                                     21,566,863        20,657,404    21,409,611       20,554,769
Diluted                                                   21,566,863        21,234,253    21,409,611       21,068,059
                                                                                                                     
1                                                                                                                    
Operating expenses include stock-based compensation as follows:                                                      
Research and development                                $        689      $        503  $      1,269     $        949
General and administrative                                       980               624         1,960            1,235
Sales and marketing                                              193               133           347              236
Total stock-based compensation                          $      1,862      $      1,260  $      3,576     $      2,420


   The accompanying notes are an integral part of these condensed financial     
                                  statements.                                   

                                       4                                        
Table of Contents
                          EVERSPIN TECHNOLOGIES, INC.                           
                  Condensed Statements of Stockholders' Equity                  
               (In thousands, except share and per share amounts)               
                                  (Unaudited)                                   
                                                                                

                                                                                                                    
                                                                      Six Months Ended June 30, 2024                
                                                                            Additional                    Total     
                                                         Common Stock        Paid-In     Accumulated   Stockholders'
                                                        Shares     Amount    Capital      Deficit         Equity    
Balance at December 31, 2023                          21,080,472    $   2    $ 191,569     $       (        $ 53,921
                                                                                             137,650                
                                                                                                   )                
Exercise of stock options                                 96,116        -          353             -             353
Issuance of common stock under stock incentive plans     229,923        -            -             -               -
Stock-based compensation expense                               -        -        1,714             -           1,714
Net loss                                                       -        -            -             (               (
                                                                                                 202             202
                                                                                                   )               )
Balance at March 31, 2024                             21,406,511    $   2    $ 193,636     $       (        $ 55,786
                                                                                             137,852                
                                                                                                   )                
Exercise of stock options                                  9,549        -           35             -              35
Issuance of common stock under stock incentive plans     240,623        -          241             -             241
Stock-based compensation expense                               -        -        1,862             -           1,862
Net loss                                                       -        -            -             (               (
                                                                                               2,502           2,502
                                                                                                   )               )
Balance at June 30, 2024                              21,656,683    $   2    $ 195,774     $       (        $ 55,422
                                                                                             140,354                
                                                                                                   )                
                                                                                                                    

                                                                                

                                                                                                                    
                                                                      Six Months Ended June 30, 2023                
                                                                            Additional                    Total     
                                                         Common Stock        Paid-In     Accumulated   Stockholders'
                                                        Shares     Amount    Capital      Deficit         Equity    
Balance at December 31, 2022                          20,374,288    $   2    $ 185,364     $       (        $ 38,664
                                                                                             146,702                
                                                                                                   )                
Exercise of stock options                                  3,020        -           13             -              13
Issuance of common stock under stock incentive plans     157,436        -            -             -               -
Stock-based compensation expense                               -        -        1,160             -           1,160
Net income                                                     -        -            -           761             761
Balance at March 31, 2023                             20,534,744    $   2    $ 186,537     $       (        $ 40,598
                                                                                             145,941                
                                                                                                   )                
Exercise of stock options                                 36,353        -          148             -             148
Issuance of common stock under stock incentive plans     172,325        -          181             -             181
Stock-based compensation expense                               -        -        1,260             -           1,260
Net income                                                     -        -            -         3,885           3,885
Balance at June 30, 2023                              20,743,422    $   2    $ 188,126     $       (        $ 46,072
                                                                                             142,056                
                                                                                                   )                
                                                                                                                    

                                                                                
   The accompanying notes are an integral part of these condensed financial     
                                  statements.                                   

                                       5                                        
Table of Contents
                          EVERSPIN TECHNOLOGIES, INC.                           
                       Condensed Statements of Cash Flow                        
                                       s                                        
                                 (In thousands)                                 
                                  (Unaudited)                                   


                                                                                                                             
                                                                                                  Six Months Ended June 30,  
                                                                                                   2024              2023    
Cash flows from operating activities                                                                                         
Net (loss) income                                                                                  $      (          $  4,646
                                                                                                      2,704                  
                                                                                                          )                  
Adjustments to reconcile net (loss) income to net cash provided by operating activities:                                     
Depreciation and amortization                                                                           795               617
Gain on sale of property and equipment                                                                    -                 (
                                                                                                                           15
                                                                                                                            )
Stock-based compensation                                                                              3,576             2,420
Loss on prepayment and termination of credit facility                                                     -               170
Non-cash warrant revaluation                                                                              -                23
Non-cash interest expense                                                                                 -                26
Changes in operating assets and liabilities:                                                                                 
Accounts receivable                                                                                   1,440             1,639
Inventory                                                                                               404                 (
                                                                                                                          662
                                                                                                                            )
Prepaid expenses and other current assets                                                               471               193
Other assets                                                                                              1                 -
Accounts payable                                                                                          (                 (
                                                                                                        595               741
                                                                                                          )                 )
Accrued liabilities                                                                                       (                 (
                                                                                                      2,628               701
                                                                                                          )                 )
Deferred revenue                                                                                          (                 (
                                                                                                        336                96
                                                                                                          )                 )
Lease liabilities, net                                                                                    4                12
Net cash provided by operating activities                                                               428             7,531
Cash flows from investing activities                                                                                         
Purchases of property and equipment                                                                       (                 (
                                                                                                      1,239             1,063
                                                                                                          )                 )
Proceeds received from sale of property and equipment                                                     -                15
Net cash used in investing activities                                                                     (                 (
                                                                                                      1,239             1,048
                                                                                                          )                 )
Cash flows from financing activities                                                                                         
Payments on long-term debt                                                                                -                 (
                                                                                                                        2,790
                                                                                                                            )
Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan          629               342
Net cash provided by (used in) financing activities                                                     629                 (
                                                                                                                        2,448
                                                                                                                            )
Net (decrease) increase in cash and cash equivalents                                                      (             4,035
                                                                                                        182                  
                                                                                                          )                  
Cash and cash equivalents at beginning of period                                                     36,946            26,795
Cash and cash equivalents at end of period                                                         $ 36,764          $ 30,830
Supplementary cash flow information:                                                                                         
Interest paid                                                                                      $      -          $     37
Operating cash flows paid for operating leases                                                     $    699          $    692
Financing cash flows paid for finance leases                                                       $     28          $      6
Non-cash investing and financing activities:                                                                                 
Right-of-use assets obtained in exchange for finance lease liabilities                             $    297          $      -
Purchases of property and equipment in accounts payable and accrued liabilities                    $     75          $      -


   The accompanying notes are an integral part of these condensed financial     
                                  statements.                                   
                                                                                

                                       6                                        
Table of Contents
                          EVERSPIN TECHNOLOGIES, INC.                           
                                                                                
                Notes to Unaudited Condensed Financial Statement                
                                       s                                        
                                                                                
1. Organization and Nature of Business

Everspin Technologies, Inc. (the Company) was incorporated in Delaware on May 
16, 2008. The Company's magnetoresistive random-access memory (MRAM) solutions 
offer the persistence of non-volatile memory with the speed and endurance of 
random-access memory (RAM) and enable the protection of mission critical data 
particularly in the event of power interruption or failure. The Company's MRAM 
solutions allow its customers in key markets, such as industrial, medical, 
automotive/transportation, aerospace and data center markets to design high 
performance, power efficient and reliable systems without the need for bulky 
batteries or capacitors.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared 
in accordance with generally accepted accounting principles in the United 
States of America (GAAP) and applicable rules and regulations of the 
Securities and Exchange Commission (SEC) regarding interim financial 
reporting. As permitted under those rules, certain footnotes or other 
financial information that are normally required by GAAP have been condensed 
or omitted, and accordingly the balance sheet as of December 31, 2023, has 
been derived from the audited financial statements at that date but does not 
include all of the information required by GAAP for complete financial 
statements. These unaudited interim condensed financial statements have been 
prepared on the same basis as the Company's annual financial statements and, 
in the opinion of management, reflect all adjustments (consisting only of 
normal recurring adjustments) that are necessary for a fair statement of the 
Company's financial information. The results of operations for the three and 
six months ended June 30, 2024, are not necessarily indicative of the results 
to be expected for the year ending December 31, 2024 or for any other interim 
period or for any other future year.

The accompanying condensed financial statements and related financial 
information should be read in conjunction with the audited financial 
statements and the related notes thereto for the year ended December 31, 2023, 
included in the Company's Annual Report on Form 10-K filed with the SEC.

Use of Estimates

The preparation of the condensed financial statements in conformity with GAAP 
requires management to make estimates and assumptions that affect the reported 
amounts of assets and liabilities and disclosure of contingent assets and 
liabilities as of the date of the condensed financial statements and the 
reported amounts of revenues and expenses during the reporting period. On an 
ongoing basis, management evaluates its estimates, including those related to 
revenue recognition, fair value of assets and liabilities, inventory net 
realizable value, deferred tax assets and related valuation allowances, and 
stock-based compensation. The Company believes its estimates and assumptions 
are reasonable; however, actual results may differ from the Company's 
estimates.

Accounts receivable, net

The Company establishes an allowance for product returns. The Company analyzes 
historical returns, current economic trends and changes in customer demand and 
acceptance of products when evaluating the adequacy of sales returns. Returns 
are processed as credits on future purchases and, as a result, the allowance 
is recorded against the balance of trade accounts receivable. In addition, the 
Company, from time to time, may establish an allowance for estimated price 
adjustments related to its distributor agreements. The Company estimates 
credits to distributors based on the historical rate of credits provided to 
distributors relative to sales and evaluation of current market conditions.

                                       7                                        
Table of Contents
Accounts receivable, net consisted of the following (in thousands):


                                                                             
                                                      June 30,   December 31,
                                                       2024         2023     
Trade accounts receivable                             $ 10,193       $ 11,489
Unbilled accounts receivable                               281            475
Allowance for product returns and price adjustments          (              (
                                                           360            410
                                                             )              )
Accounts receivable, net                              $ 10,114       $ 11,554
                                                                             


Concentration of Credit Risk

Financial instruments that potentially expose the Company to a concentration 
of credit risk consist principally of cash and cash equivalents that are held 
by a financial institution in the United States and accounts receivable. 
Amounts on deposit with a financial institution may at times exceed federally 
insured limits.

Significant customers are those which represent more than 10% of the Company's 
total revenue or net accounts receivable balance at each respective balance 
sheet date. For the purposes of this disclosure, the Company defines 
"customer" as the entity that is purchasing the products or licenses directly 
from the Company, which includes the distributors of the Company's products in 
addition to end customers that the Company sells to directly. For each 
significant customer, revenue as a percentage of total revenue and accounts 
receivable as a percentage of total accounts receivable, net are as follows:



                                                                                     
                             Revenue                      Accounts Receivable, net   
             Three Months Ended     Six Months Ended               As of             
                  June 30,              June 30,         June 30,      December 31,  
Customers    2024          2023     2024         2023      2024            2023      
Customer A       *            17 %     *           16 %         *                13 %
Customer B       *            13 %     *           14 %         *                 *  
Customer C       *            10 %    12 %          *           *                22 %
Customer D      26 %          13 %    25 %         15 %        53 %              37 %
Customer E      14 %          13 %     *           12 %        11 %               *  

*
Less than 10%

Fair Value of Financial Instruments

Fair value is defined as an exit price, representing the amount that would be 
received to sell an asset, or paid to transfer a liability, in an orderly 
transaction between market participants. The framework for measuring fair 
value provides a three-tier hierarchy prioritizing inputs to valuation 
techniques used in measuring fair value as follows:

Level 1- Observable inputs such as quoted prices for identical assets or 
liabilities in active markets;

Level 2- Inputs, other than quoted prices for identical assets or liabilities 
in active markets, which are observable either directly or indirectly; and

Level 3- Unobservable inputs in which there is little or no market data 
requiring the reporting entity to develop its own assumptions.

The carrying value of accounts receivable, accounts payable, and other 
accruals readily convertible into cash approximate fair value because of the 
short-term nature of the instruments. The Company's financial instruments 
consist of Level 1 assets. Where quoted prices are available in an active 
market, securities are classified as Level 1. Level 1 assets consist of highly 
liquid money market funds that are included in cash equivalents.

                                       8                                        
Table of Contents
The following tables sets forth the fair value of the Company's financial 
assets and liabilities measured at fair value on a recurring basis (in 
thousands):


                                                                           
                                                 June 30, 2024             
                                      Level 1   Level 2   Level 3   Total  
Assets:                                                                    
Money market funds                   $ 36,764    $    -    $    -  $ 36,764
Total assets measured at fair value  $ 36,764    $    -    $    -  $ 36,764
                                                                           



                                                                           
                                               December 31, 2023           
                                      Level 1   Level 2   Level 3   Total  
Assets:                                                                    
Money market funds                   $ 36,946    $    -    $    -  $ 36,946
Total assets measured at fair value  $ 36,946    $    -    $    -  $ 36,946
                                                                           


Recently Issued Accounting Pronouncements Under Evaluation

In November 2023, the FASB issued ASU No. 2023-07,
Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures
, which improves reportable segment disclosure requirements, primarily through 
enhanced disclosures about significant segment expenses. This ASU also expands 
disclosure requirements to enable users of financial statements to better 
understand the entity's measurement and assessment of segment performance and 
resource allocation. This guidance is effective for fiscal years beginning 
after December 15, 2023, and interim periods within fiscal years beginning 
after December 15, 2024, with early adoption permitted. The Company is 
currently evaluating the impact that the standard will have on its condensed 
financial statements.

In December 2023, the FASB issued ASU No. 2023-09
, Income Taxes (Topic 740): Improvements to Income Tax Disclosures
, which is intended to improve an entity's income tax disclosures, primarily 
through disaggregated information about an entity's effective income tax rate 
reconciliation and additional disclosures regarding income taxes paid. ASU 
2023-09 is effective for the Company's annual reporting periods, and interim 
periods within those years, beginning after December 15, 2024, on a 
prospective basis. The Company is currently evaluating the impact that the 
standard will have on its condensed financial statements.

The Company
reviewed
all other recently issued accounting pronouncements and concluded that they 
were either not applicable or not expected to have a significant impact to the 
condensed financial statements.

3. Revenue

The Company sells products to its distributors, original design manufacturers 
(ODMs), and original equipment manufacturers (OEMs). The Company also 
recognizes revenue under licensing, patent, and royalty agreements with some 
customers.

The following table presents the Company's revenues disaggregated by sales 
channel (in thousands):


                                                                               
                   Three Months Ended June 30,      Six Months Ended June 30,  
                     2024               2023         2024              2023    
Distributor          $  9,227           $ 12,365     $ 19,514          $ 25,207
Non-distributor         1,409              3,382        5,552             5,386
Total revenue        $ 10,636           $ 15,747     $ 25,066          $ 30,593


                                       9                                        
Table of Contents
The following table presents the Company's revenues disaggregated by timing of 
recognition (in thousands):

                                                                             
                 Three Months Ended June 30,      Six Months Ended June 30,  
                   2024               2023         2024              2023    
Point in time      $ 10,062           $ 13,790     $ 21,029          $ 27,660
Over time               574              1,957        4,037             2,933
Total revenue      $ 10,636           $ 15,747     $ 25,066          $ 30,593


The following table presents the Company's revenues disaggregated by type (in 
thousands):


                                                                             
                 Three Months Ended June 30,      Six Months Ended June 30,  
                   2024               2023         2024              2023    
Product sales      $  9,887           $ 13,406     $ 20,747          $ 27,183
Licensing               306              1,899        3,527             2,817
Royalties               175                236          282               329
Patents                   -                  -            -                 -
Other revenue           268                206          510               264
Total revenue      $ 10,636           $ 15,747     $ 25,066          $ 30,593
                                                                             


The Company recognizes revenue in
three
primary geographic regions: Asia-Pacific (APAC); North America; and Europe, 
Middle East and Africa (EMEA). The Company recognizes revenue by geography 
based on the region in which the Company's products are sold, and not to where 
the end products in which they are assembled are shipped. The Company's 
revenue by region for the periods indicated was as follows (in thousands):



                                                                             
                 Three Months Ended June 30,      Six Months Ended June 30,  
                   2024               2023         2024              2023    
APAC               $  6,310           $  7,964     $ 13,240          $ 15,555
North America         3,051              4,517        5,843             8,847
EMEA                  1,275              3,266        5,983             6,191
Total revenue      $ 10,636           $ 15,747     $ 25,066          $ 30,593



4. Balance Sheet Components

Inventory

Inventory consisted of the following (in thousands):


                                         
                  June 30,   December 31,
                   2024         2023     
Raw materials      $   105       $    189
Work-in-process      6,754          6,724
Finished goods       1,128          1,478
Total inventory    $ 7,987       $  8,391
                                         


Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):


                                                   
                            June 30,   December 31,
                             2024         2023     
Payroll-related expenses     $ 1,093       $  3,347
Inventory                        259            317
Other                            408            672
Total accrued liabilities    $ 1,760       $  4,336


                                       10                                       
Table of Contents
Deferred Revenue

During the year ended December 31, 2021, the Company executed contractual 
arrangements with a customer for the development of a RAD-Hard product, 
consisting of a technology license, design license agreement and development 
subcontract (RAD-Hard 1). The Company does not share in the rights to future 
revenues or royalties. The total arrangements are for $
6.5
million in consideration.

The Company concluded these contractual arrangements represent one arrangement 
and evaluated its promises to the customer and whether the performance 
obligations granted under the arrangement were distinct. The licenses provided 
to the customer are not transferable, are of limited value without the 
promised development services, and the customer cannot benefit from the 
license agreements without the specific obligated services in the development 
subcontract, as there is strong interdependency between the licenses and the 
development subcontract. Accordingly, the Company determined the licenses were 
not distinct within the context of the contract and combined the license with 
other performance obligations. The total transaction price of $
6.5
million was allocated to the single performance obligation.
The Company recognizes revenue related to the performance obligations over 
time using the input method based on costs incurred to date relative to the 
total expected costs of the contract and began recognizing revenue in the 
second quarter of 2021 over the contract period. This method depicts 
performance under the contract and requires the Company to make estimates 
about the future costs expected to be incurred to perform under the contact, 
including labor and material costs.

The Company has recognized $
0.3
million and $
0.5
million in revenue for the three and six months ended June 30, 2024, 
respectively, and $
6.2
million in revenue since inception of the contractual agreements. The Company 
expects to recognize the remaining $
0.3
million of the transaction price as services are performed throughout the 
contractual period and performance is expected to be complete in the year 
ending December 31, 2024.

5. Leases

Operating leases consist primarily of office space expiring at various dates 
through 2029. Finance leases relate to server leases expiring at various dates 
through 2029. The Company's lease agreements do not contain any material 
residual value guarantees or material restrictive covenants.

The undiscounted future non-cancellable lease payments under the Company's 
operating and finance leases were as follows (in thousands):


                                                        
As of June 30, 2024                               Amount
2024                                             $   739
2025                                               1,482
2026                                               1,497
2027                                               1,380
2028                                                 595
Thereafter                                            48
Total lease payments                               5,741
Less: imputed interest                                 (
                                                     470
                                                       )
Total lease liabilities                            5,271
Less: current portion of lease liabilities             (
                                                   1,275
                                                       )
Total lease liabilities, net of current portion  $ 3,996


Other information related to the Company's operating lease liabilities was as 
follows:


                                                                       
                                                June 30,   December 31,
                                                 2024         2023     
Weighted-average remaining lease term (years)  3.88         4.37       
Weighted-average discount rate                 4.50 %       4.50 %     


                                       11                                       
Table of Contents
Other information related to the Company's finance lease liabilities was as 
follows:


                                                                       
                                                June 30,   December 31,
                                                 2024         2023     
Weighted-average remaining lease term (years)  4.57         1.09       
Weighted-average discount rate                 3.91 %       4.50 %     



6. Debt

2019 Credit Facility

In March 2023, our credit facility with a lender pursuant to an Amended and 
Restated Loan and Security Agreement (the 2019 Credit Facility), consisting of 
a term loan and line of credit, was paid in full, and there was
no
outstanding balance as of June 30, 2024. The Company paid an early termination 
and prepayment fee of $
170,000
, which was recorded within other income (expense) within the condensed 
statements of operations and comprehensive (loss) income for the six months 
ended June 30, 2023.

The Company was in compliance with all covenants throughout the 2019 Credit 
Facility payoff date in March 2023.

The amortization of the debt issuance costs and accretion of the debt discount 
is included in interest expense within the condensed statements of operations 
and comprehensive (loss) income and included in non-cash interest expense 
within the statement of cash flows.

7. Stock-Based Compensation

Summary of Stock Option and Award Activity

The following table summarizes the stock option and award activity for the six 
months ended June 30, 2024:


                                                                                                      
                                                                  Options Outstanding                 
                                                              Weighted-   Weighted-                   
                                    Options and               Average      Average        Aggregate   
                                      Awards                  Exercise    Remaining       Intrinsic   
                                   Available for  Number of   Price Per   Contractual       Value     
                                       Grant       Options     Share     Life (years)   (In thousands)
Balance-December 31, 2023                598,397  1,829,428      $ 5.96           6.9        $   5,676
Authorized                               632,414                                                      
RSUs granted                                   (                                                      
                                         977,783                                                      
                                               )                                                      
RSUs cancelled/forfeited                  10,007                                                      
Warrants exercised                             -                                                      
Options granted                                -          -           -                               
Options exercised                              -          (      $ 3.67                      $     498
                                                    106,741                                           
                                                          )                                           
Options cancelled/forfeited                3,951          (      $ 6.22                               
                                                      4,565                                           
                                                          )                                           
Balance-June 30, 2024                    266,986  1,718,122      $ 6.10           6.5        $   1,255
Options exercisable-June 30, 2024                 1,369,585      $ 5.86           6.2        $   1,197


The total grant date fair value of options vested was $
0.3
million and $
0.4
million during the three months ended June 30, 2024 and 2023, respectively, 
and $
0.7
million and $
1.3
million during the six months ended June 30, 2024 and 2023, respectively.

The weighted-average grant date fair value of options granted was $
4.43
per share during the three months ended June 30, 2023 and $
3.85
per share during the six months ended June 30, 2023.
No
shares were granted in the three and six months ended June 30, 2024.

As of June 30, 2024, there was $
1.6
million of total unrecognized stock-based compensation expense related to 
unvested options which is expected to be recognized over a weighted-average 
period of
1.28
years. Stock-based compensation cost for options capitalized within inventory 
at June 30, 2024 and 2023 was not material.
                                       12                                       
Table of Contents

2016 Employee Stock Purchase Plan

In January 2024, there was an increase of
210,804
shares reserved for issuance under the Company's Employee Stock Purchase Plan 
(ESPP) pursuant to the terms of the ESPP. The Company had
1,063,270
shares available for future issuance under the Company's ESPP as of June 30, 
2024. Employees purchased
37,696
shares for $
241,000
during the three and six months ended June 30, 2024. Employees purchased
40,894
shares for $
181,000
during the three and six months ended June 30, 2023.

Restricted Stock Units

The following table summarizes restricted stock units (RSUs) activity for the 
six months ended June 30, 2024:


                                                            
                                   RSUs Outstanding         
                                                Weighted-   
                                                 Average    
                              Number of        Grant Date   
                           Restricted Stock   Fair Value Per
                                Units             Share     
Balance-December 31, 2023           905,781        $    6.59
Granted                             977,783        $    8.62
Vested                                    (        $    6.69
                                    433,100                 
                                          )                 
Cancelled/forfeited                       (        $    7.12
                                     10,007                 
                                          )                 
Balance-June 30, 2024             1,440,457        $    7.93


The fair value of RSUs is determined on the date of grant based on the market 
price of the Company's common stock on that date.

As of June 30, 2024,
there was
$
10.1
million of unrecognized stock-based compensation expense related to RSUs to be 
recognized over a weighted-average period of
2.6
years. Stock-based compensation cost related to RSUs capitalized within 
inventory at June 30, 2024 and 2023 was not material.

8. Significant Agreements

GLOBALFOUNDRIES, Inc. Joint Development Agreement

Since October 17, 2014, the Company has participated in a joint development 
agreement (JDA) with GLOBALFOUNDRIES Inc. (GF), a semiconductor foundry, for 
the joint development of Spin-transfer Torque MRAM (STT-MRAM), technology to 
produce a family of discrete and embedded MRAM technologies. The term of the 
JDA is until the completion, termination, or expiration of the last statement 
of work entered into pursuant to the JDA. The JDA was extended on December 31, 
2019, to include a new phase of support for 12nm MRAM development.

Under the current JDA extension terms, each party licenses its relevant 
intellectual property to the other party. For certain jointly developed works, 
the parties have agreed to follow an invention allocation procedure to 
determine ownership. In addition, GF possesses the exclusive right to 
manufacture the Company's discrete and embedded STT-MRAM devices developed 
pursuant to the JDA until the earlier of
three years
after the qualification of the MRAM device for a particular technology node or
four years
after the completion of the relevant statement of work under which the device 
was developed. For the same exclusivity period associated with the relevant 
device, GF agreed not to license intellectual property developed in connection 
with the JDA to named competitors of the Company.
If GF manufactures, sells, or transfers to customers wafers containing 
production quantified STT-MRAM devices that utilize certain design 
information, GF will be required to pay the Company a royalty.

9. Net (Loss) Income Per Common Share

Basic net (loss) income per common share is calculated by dividing the net 
income by the weighted-average number of shares of common stock outstanding 
for the period less shares subject to repurchase, without consideration of 
potentially dilutive securities. Diluted earnings per share is calculated 
using the treasury stock method by dividing net income by the
                                       13                                       
Table of Contents
total weighted average shares of common stock outstanding in addition to the 
potential impact of dilutive securities including restricted stock units, 
warrants, and options. In periods with a net loss, potentially dilutive 
securities are excluded from the Company's calculation of earnings per share 
as their inclusion would have an antidilutive effect.

The following tables set forth the computation of basic and diluted net (loss) 
income per share attributable to common stockholders (in thousands, except 
share and per share amounts):

Basic EPS


                                                                                                                          
                                                              Three Months Ended June 30,      Six Months Ended June 30,  
                                                                2024              2023           2024            2023     
Numerator:                                                                                                                
Net (loss) income                                            $          (      $      3,885  $          (     $      4,646
                                                                    2,502                           2,704                 
                                                                        )                               )                 
Denominator:                                                                                                              
Weighted-average shares of common stock outstanding, basic     21,566,863        20,657,404    21,409,611       20,554,769
Net (loss) income per common share, basic                    $          (      $       0.19  $          (     $       0.23
                                                                     0.12                            0.13                 
                                                                        )                               )                 
                                                                                                                          


Diluted EPS


                                                                                                                              
                                                                  Three Months Ended June 30,      Six Months Ended June 30,  
                                                                    2024              2023           2024            2023     
Numerator:                                                                                                                    
Net (loss) income                                                $          (      $      3,885  $          (     $      4,646
                                                                        2,502                           2,704                 
                                                                            )                               )                 
Warrant liability fair value loss recognized                                -                 -             -               23
Net (loss) income attributable to common stockholders, diluted   $          (      $      3,885  $          (     $      4,669
                                                                        2,502                           2,704                 
                                                                            )                               )                 
Denominator:                                                                                                                  
Weighted-average shares of common stock outstanding, basic         21,566,863        20,657,404    21,409,611       20,554,769
Dilutive effect of stock options and RSUs                                   -           576,849             -          513,290
Weighted-average shares of common stock outstanding, diluted       21,566,863        21,234,253    21,409,611       21,068,059
Net (loss) income per common share, diluted                      $          (      $       0.18  $          (     $       0.22
                                                                         0.12                            0.13                 
                                                                            )                               )                 


Potentially dilutive securities representing
2.1
million and
0.9
million stock options and RSUs that were outstanding during the three months 
ended June 30, 2024, and 2023, respectively, and
1.7
million and
1.3
million stock options and RSUs outstanding during the six months ended June 
30, 2024 and 2023, respectively, were excluded from the computation of diluted 
earnings per common share during these periods as their inclusion would have 
an antidilutive effect.


                                       14                                       
Table of Contents


Item 2. Management's Discussion and Analysi
s of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial 
condition and results of operations together with our condensed financial 
statements and related notes included in Part I, Item 1 of this report and 
with our audited financial statements and related notes thereto included as 
part of our Annual Report on Form 10-K for the year ended December 31, 2023.


Forward-Looking Statements

This discussion contains certain forward-looking statements within the meaning 
of Section 27A of the Securities Act of 1933, as amended (Securities Act), and 
Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act). 
Forward-looking statements are identified by words such as "believe," "will," 
"may," "estimate," "continue," "anticipate," "intend," "should," "plan," 
"expect," "predict," "could," "potentially" or the negative of these terms or 
similar expressions. You should read these statements carefully because they 
discuss future expectations, contain projections of future results of 
operations or financial condition, or state other "forward-looking" 
information. These statements relate to, among other things, our industry, 
business, future plans, strategies, objectives, expectations, intentions and 
financial performance. These forward-looking statements are subject to certain 
risks and uncertainties that could cause actual results to differ materially 
from those anticipated in the forward-looking statements. Factors that might 
cause such a difference include, but are not limited to, those discussed in 
this report in Part II, Item 1A - "Risk Factors," and elsewhere in this 
report, as well as in our other filings with the Securities and Exchange 
Commission (SEC). Forward-looking statements are based on our management's 
beliefs and assumptions and on information currently available to our 
management. These statements, like all statements in this report, speak only 
as of their date, and we undertake no obligation to update or revise these 
statements in light of future developments.
In addition, statements that "we believe" and similar statements reflect our 
beliefs and opinions on the relevant subject. These statements are based on 
information available to us as of the date of this Quarterly Report on Form 
10-Q. While we believe that information provides a reasonable basis for these 
statements, that information may be limited or incomplete. Our statements 
should not be read to indicate that we have conducted an exhaustive inquiry 
into or review of, all relevant information. These statements are inherently 
uncertain and investors are cautioned not to unduly rely on these statements.

We caution investors that our business and financial performance are subject 
to substantial risks and uncertainties.

Overview

Everspin is a pioneer in the successful commercialization of Magnetoresistive 
Random Access Memory (MRAM) technology. Our portfolio of MRAM technologies, 
including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), is delivering 
superior performance, persistence and reliability in non-volatile memories 
that transform how mission-critical data is protected against power loss. With 
over 15 years of MRAM technology and manufacturing leadership, our memory 
solutions deliver significant value to our customers in key markets such as 
industrial, medical, automotive/transportation, aerospace and data center. We 
are the leading supplier of discrete MRAM components and a successful licensor 
of our broad portfolio of related technology intellectual property.

We sell our products directly and through our established distribution 
channels to industry-leading OEMs and ODMs.
We manufacture our MRAM products using both captive and third-party 
manufacturing capabilities. We purchase industry-standard complementary 
metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and 
perform back end of line (BEOL) processing that includes our magnetic-bit 
technology at our 200mm fabrication facility in Chandler, Arizona. We also 
manufacture full-flow 300mm CMOS wafers with our STT-MRAM magnetic-bit 
technology integrated in BEOL as part of our strategic relationship with 
GLOBALFOUNDRIES.
Key Metrics

We monitor a variety of key financial metrics to help us evaluate trends, 
establish budgets, measure the effectiveness of our business strategies and 
assess operational efficiencies. These financial metrics include revenue, 
gross margin, operating expenses and operating income determined in accordance 
with GAAP. Additionally, we monitor and project cash flow to determine our 
sources and uses for working capital to fund our operations. We also monitor 
Adjusted EBITDA, a non-GAAP financial measure, and design wins. We define 
Adjusted EBITDA as net income or loss adjusted
                                       15                                       
Table of Contents
for interest expense, taxes, depreciation and amortization, stock-based 
compensation expense, and restructuring costs, if any.
Adjusted EBITDA.
Our management and board of directors use Adjusted EBITDA to understand and 
evaluate our operating performance and trends, to prepare and approve our 
annual budget and to develop short-term and long-term operating and financing 
plans. Accordingly, we believe that Adjusted EBITDA provides useful 
information for investors in understanding and evaluating our operating 
results in the same manner as our management and our board of directors. 
Adjusted EBITDA is a non-GAAP financial measure and should be considered in 
addition to, not as superior to, or as a substitute for, net income reported 
in accordance with GAAP. The following table presents a reconciliation of net 
income, the most directly comparable GAAP measure, to Adjusted EBITDA for the 
periods indicated:

                                                                                                
                                    Three Months Ended June 30,      Six Months Ended June 30,  
                                      2024               2023          2024              2023   
Adjusted EBITDA reconciliation:                                                                 
Net (loss) income                     $ (2,502)           $ 3,885     $ (2,704)          $ 4,646
Depreciation and amortization               397               284           795              617
Stock-based compensation expense          1,862             1,260         3,576            2,420
Interest expense                              -                 -             -               63
Income tax (benefit) expense                 76                 -            76                -
Adjusted EBITDA                       $   (167)           $ 5,429     $   1,743          $ 7,746



                                       16                                       
Table of Contents
Results of Operations

The following tables set forth our results of operations for the periods 
indicated:


                                                                                                              
                                                                    Three Months Ended June 30,               
                                                         2024       2023        2024                2023      
                                                         (In thousands)       (As a percentage of revenue)    
Product sales                                          $   9,887  $ 13,406            93 %                85 %
Licensing, royalty, patent, and other revenue                749     2,341             7                  15  
Total revenue                                             10,636    15,747           100                 100  
Cost of product sales                                      5,235     6,090            49                  39  
Cost of licensing, royalty, patent, and other revenue        185       464             2                   3  
Total cost of sales                                        5,420     6,554            51                  42  
Gross profit                                               5,216     9,193            49                  58  
Operating expenses:                                                                                           
Research and development                                   3,457     2,708            33                  17  
General and administrative                                 3,254     3,507            31                  22  
Sales and marketing                                        1,324     1,355            12                   9  
Total operating expenses                                   8,035     7,570            76                  48  
(Loss) income from operations                            (2,819)     1,623          (27)                  10  
Other income, net                                            393     2,262             4                  14  
Net (loss) income before income taxes                    (2,426)     3,885          (23)                  25  
Income tax (expense) benefit                                (76)         -           (1)                   -  
Net (loss) income and comprehensive (loss) income      $ (2,502)  $  3,885          (24) %                25 %



                                                                                                              
                                                                     Six Months Ended June 30,                
                                                         2024       2023        2024                2023      
                                                         (In thousands)       (As a percentage of revenue)    
Product sales                                          $  20,747  $ 27,183            83 %                89 %
Licensing, royalty, patent, and other revenue              4,319     3,410            17                  11  
Total revenue                                             25,066    30,593           100                 100  
Cost of product sales                                     11,238    12,213            45                  40  
Cost of licensing, royalty, patent, and other revenue        452       757             2                   2  
Total cost of sales                                       11,690    12,970            47                  42  
Gross profit                                              13,376    17,623            53                  58  
Operating expenses:                                                                                           
Research and development                                   6,875     5,907            27                  19  
General and administrative                                 7,290     6,727            29                  22  
Sales and marketing                                        2,630     2,670            10                   9  
Total operating expenses                                  16,795    15,304            67                  50  
(Loss) income from operations                            (3,419)     2,319          (14)                   8  
Interest expense                                               -      (63)             -                   -  
Other income, net                                            791     2,390             3                   8  
Net (loss) income before income taxes                    (2,628)     4,646          (10)                  15  
Income tax (expense) benefit                                (76)         -             -                   -  
Net (loss) income and comprehensive (loss) income      $ (2,704)  $  4,646          (11) %                15 %



Comparison of the three months ended June 30, 2024 and 2023

Revenue

We generated 87% and 79% of our revenue from products sold to distributors for 
the three months ended June 30, 2024 and 2023, respectively.
In addition to selling our products to our distributors, we maintain a direct 
selling relationship, for strategic purposes, with several key customer 
accounts. We have organized our sales team and representatives into three 
primary
                                       17                                       
Table of Contents
regions: North America; EMEA; and APAC. We recognize revenue by geography 
based on the region in which our customer is located and to which our products 
are sold, and not to where the end products in which they are assembled are 
shipped. Our revenue by region and by type of revenue for the periods 
indicated were as follows (in thousands):

                                              
                 Three Months Ended June 30,  
                   2024               2023    
APAC               $  6,310           $  7,964
North America         3,051              4,517
EMEA                  1,275              3,266
Total revenue      $ 10,636           $ 15,747



                                                                                          
                                                 Three Months Ended                       
                                                      June 30,              Change        
                                                 2024         2023      Amount      %     
                                                        (Dollars in thousands)            
Product sales                                   $  9,887     $ 13,406  $ (3,519)  (26.2) %
Licensing, royalty, patent, and other revenue        749        2,341    (1,592)  (68.0) %
Total revenue                                   $ 10,636     $ 15,747  $ (5,111)  (32.5) %
                                                                                          


Total revenue decreased by $5.1 million, or 32.5%, from $15.7 million during 
the three months ended June 30, 2023 to $10.6 million during the three months 
ended June 30, 2024. The decrease was primarily due to a decrease in product 
sales of $3.5 million due to timing of customer demand, and a decrease in 
licensing revenue generated from our RAD-Hard projects of $1.5 million, along 
with a decrease of $0.1 million in other revenue related to foundry services.

Licensing, royalty, patent, and other revenue is a highly variable revenue 
item characterized by a small number of transactions annually with revenue 
based on size and terms of each transaction. Our best estimate of royalty 
revenue earned is made throughout the year for royalty contracts with an 
annual performance period, with an annual adjustment recognized for actual 
sales in the first quarter of each fiscal year. Licensing, royalty, patent, 
and other revenue decreased by $1.6 million, or 68.0% from $2.3 million during 
the three months ended June 30, 2023, to $0.7 million during the three months 
ended June 30, 2024. The decrease was driven by a decrease of $1.5 million in 
licensing revenue generated from our RAD-Hard projects, along with a decrease 
of $0.1 million of other revenue related to foundry services.

Cost of Sales and Gross Margin


                                                                                                   
                                                         Three Months Ended                        
                                                              June 30,               Change        
                                                         2024         2023       Amount      %     
                                                                 (Dollars in thousands)            
Cost of product sales                                   $ 5,235       $ 6,090   $   (855)  (14.0) %
Cost of licensing, royalty, patent, and other revenue       185           464       (279)  (60.1) %
Total cost of sales                                     $ 5,420       $ 6,554   $ (1,134)  (17.3) %
Gross margin                                               49.0 %        58.4 %                    
                                                                                                   


Cost of product sales decreased by $0.9 million, or 14.0%, from $6.1 million 
during the three months ended June 30, 2023, to $5.2 million during the three 
months ended June 30, 2024. The decrease was primarily due to a reduction in 
product sales, partially offset by increased yields on our toggle products.

Cost of licensing, royalty, patent, and other revenue decreased by $0.3 
million, or 60.1% from $0.5 million during the three months ended June 30, 
2023, to $0.2 million during the three months ended June 30, 2024. The 
decrease was primarily due to a decrease in licensing costs related to labor 
and materials associated with the progression of our RAD-Hard projects.

Gross margin decreased from 58.4% during the three months ended June 30, 2023, 
to 49.0% during the three months ended June 30, 2024. Gross margin decreased 
as a result of a decrease in product sales and licensing revenue, partially 
offset by increased yields on our toggle products.
                                       18                                       
Table of Contents

Operating Expenses

Our operating expenses consist of research and development, general and 
administrative and sales and marketing expenses. Personnel-related expenses, 
including salaries, benefits, bonuses and stock-based compensation, are among 
the most significant components of each of our operating expense categories.

                                                                                    
                                              Three Months Ended                    
                                                   June 30,             Change      
                                              2024         2023       Amount   %    
                                                    (Dollars in thousands)          
Research and development                     $ 3,457       $ 2,708     $ 749  27.7 %
Research and development as a % of revenue        33 %          17 %                


Research and Development Expenses.
Research and development expenses increased by $0.7 million, or 27.7%, from 
$2.7 million during the three months ended June 30, 2023, to $3.5 million 
during the three months ended June 30, 2024. The primary driver of research 
and development expenses relates to our new Extended Serial Peripheral 
Interface (xSPI) family of STT-MRAM products. Our xSPI products offer 
high-performance, multiple I/O, SPI-compatibility and feature a high-speed, 
low pin count SPI compatible interface.


                                                                                       
                                                Three Months Ended                     
                                                     June 30,              Change      
                                                2024         2023       Amount    %    
                                                      (Dollars in thousands)           
General and administrative                     $ 3,254       $ 3,507   $ (253)  (7.2) %
General and administrative as a % of revenue        31 %          22 %                 


General and Administrative Expenses.
General and administrative expenses decreased by $0.3 million, or 7.2%, from 
$3.5 million during the three months ended June 30, 2023, to $3.2 million 
during the three months ended June 30, 2024. The decrease is primarily due to 
reduced professional services costs.


                                                                                
                                         Three Months Ended                     
                                              June 30,              Change      
                                         2024         2023       Amount    %    
                                               (Dollars in thousands)           
Sales and marketing                     $ 1,324       $ 1,355    $ (31)  (2.3) %
Sales and marketing as a % of revenue        12 %           9 %                 


Sales and Marketing Expenses.
Sales and marketing expenses remained consistent at $1.3 million during the 
three months ended June 30, 2024 and 2023, respectively. Sales and marketing 
expenses relate primarily to compensation costs and contract labor.

Other Income (Expense), Net


                                                              
                     Three Months Ended                       
                          June 30,              Change        
                    2024          2023      Amount      %     
                             (Dollars in thousands)           
Other income, net    $ 393        $ 2,262  $ (1,869)  (82.6) %


Other income, net decreased by $1.9 million in income for the three months 
ended June 30, 2024. The change was primarily due to an employee retention tax 
credit of $2.0 million during the three months ended June 30, 2023, partially 
offset by interest income.

Comparison of the six months ended June 30, 2024 and 2023

Revenue

We generated 78% and 82% of our revenue from products sold to distributors for 
the six months ended June 30, 2024 and 2023, respectively.
                                       19                                       
Table of Contents
Our revenue by region and by type of revenue for the periods indicated were as 
follows (in thousands).

                                            
                 Six Months Ended June 30,  
                  2024              2023    
APAC              $ 13,240          $ 15,555
North America        5,843             8,847
EMEA                 5,983             6,191
Total revenue     $ 25,066          $ 30,593



                                                                                        
                                                 Six Months Ended                       
                                                     June 30,             Change        
                                                 2024        2023     Amount      %     
                                                       (Dollars in thousands)           
Product sales                                  $ 20,747    $ 27,183  $ (6,436)  (23.7) %
Licensing, royalty, patent, and other revenue     4,319       3,410        909    26.7 %
Total revenue                                  $ 25,066    $ 30,593  $ (5,527)  (18.1) %


Total revenue decreased by $5.5 million, or 18.1%, from $30.6 million during 
the six months ended June 30, 2023 to $25.1 million during the six months 
ended June 30, 2024. The decrease was primarily due to a decrease in product 
sales of $6.4 million due to timing of customer demand, offset by an increase 
in licensing revenue generated from our RAD-Hard projects of $0.7 million, 
along with an increase of $0.2 million in other revenue related to foundry 
services.

Licensing, royalty, patent and other revenue is a highly variable revenue item 
characterized by a small number of transactions annually with revenue based on 
size and term of each transaction Our best estimate of royalty revenue earned 
is made through the year, with an annual adjustment recognized for actual 
sales in the first quarter of each fiscal year. Licensing, royalty, patent, 
and other revenue increased by $0.9 million, or 26.7%, from $3.4 million 
during the six months ended June 30, 2023, to $4.3 million during the six 
months ended June 30, 2024. The increase was driven by an increase of $0.7 
million in licensing revenue generated from our RAD-Hard projects, along with 
an increase of $0.2 million of other revenue related to foundry services.

Cost of Sales and Gross Margin


                                                                                                 
                                                         Six Months Ended                        
                                                             June 30,              Change        
                                                         2024       2023       Amount      %     
                                                                (Dollars in thousands)           
Cost of product sales                                  $ 11,238    $ 12,213   $   (975)   (8.0) %
Cost of licensing, royalty, patent, and other revenue       452         757       (305)  (40.3) %
Total cost of sales                                    $ 11,690    $ 12,970   $ (1,280)   (9.9) %
Gross margin                                               53.4 %      57.6 %                    


Cost of product sales decreased by $1.0 million, or 8.0%, from $12.2 million 
during the six months ended June 30, 2023, to $11.2 million during the six 
months ended June 30, 2024. The decrease was primarily due to a reduction in 
product sales and increased yields on our toggle products.

Cost of licensing, royalty, patent, and other revenue decreased by $0.3 
million, or 40.3% from $0.8 million during the six months ended June 30, 2023, 
to $0.5 million during the six months ended June 30, 2024. The decrease was 
due to a decrease in licensing costs related to labor and materials associated 
with the progression of our RAD-Hard projects.

Gross margin decreased from 57.6% during the six months ended June 30, 2023, 
to 53.4% during the six months ended June 30, 2024. Gross margin decreased as 
a result of a decrease in product sales and increased yields on our toggle 
products, partially offset by increased licensing revenue.

                                       20                                       
Table of Contents
Operating Expenses

Our operating expenses consist of research and development, general and 
administrative and sales and marketing expenses. Personnel-related expenses, 
including salaries, benefits, bonuses and stock-based compensation, are among 
the most significant components of each of our operating expense categories.

                                                                                           
                                              Six Months Ended June 30,        Change      
                                               2024              2023        Amount   %    
                                                       (Dollars in thousands)              
Research and development                        $ 6,875           $ 5,907     $ 968  16.4 %
Research and development as a % of revenue           27 %              19 %                


Research and Development Expenses.
Research and development expenses increased by $1.0 million, or 16.4%, from 
$5.9 million during the six months ended June 30, 2023, to $6.9 million during 
the six months ended June 30, 2024. The primary driver of research and 
development expenses relates to our new xSPI family of STT-MRAM products.



                                                                                            
                                                Six Months Ended June 30,        Change     
                                                 2024              2023        Amount   %   
                                                         (Dollars in thousands)             
General and administrative                        $ 7,290           $ 6,727     $ 563  8.4 %
General and administrative as a % of revenue           29 %              22 %               


General and Administrative Expenses.
General and administrative expenses increased by $0.6 million, or 8.4%, from 
$6.7 million during the six months ended June 30, 2023, to $7.3 million during 
the six months ended June 30, 2024. The increase is primarily due to increases 
related to stock-based compensation and professional services.


                                                                                       
                                         Six Months Ended June 30,         Change      
                                          2024              2023        Amount    %    
                                                   (Dollars in thousands)              
Sales and marketing                        $ 2,630           $ 2,670    $ (40)  (1.5) %
Sales and marketing as a % of revenue           10 %               9 %                 


Sales and Marketing Expenses.
Sales and marketing expenses remained consistent at $2.6 million during the 
six months ended June 30, 2024 and 2023, respectively.

Interest Expense

                                                          
                    Six Months Ended                      
                        June 30,             Change       
                   2024         2023     Amount     %     
                          (Dollars in thousands)          
Interest expense    $   -        $  63   $ (63)  (100.0) %


Interest expense decreased by $0.1 million, or 100.0%, from $0.1 million 
during the six months ended June 30, 2023, to $0 during the six months ended 
June 30, 2024. The decrease was due to having no outstanding balance under our 
2019 Credit Facility that we paid off in full in March 2023, resulting in no 
interest incurred during the six months ended June 30, 2024.

Other Income (Expense), Net

                                                            
                     Six Months Ended                       
                         June 30,             Change        
                    2024        2023      Amount      %     
                            (Dollars in thousands)          
Other income, net   $ 791       $ 2,390  $ (1,599)  (66.9) %


Other income, net decreased by $1.6 million in income for the six months ended 
June 30, 2024. The change was primarily due to an employee retention tax 
credit of $2.0 million during the six months ended June 30, 2023, partially 
offset by interest income.

                                       21                                       
Table of Contents
Liquidity and Capital Resources

As of June 30, 2024, we had $36.8 million of cash and cash equivalents, 
compared to $36.9 million as of December 31, 2023. As of June 30, 2024, we 
have no outstanding debt as we paid off our 2019 Credit Facility in full in 
March 2023. We believe our cash and cash equivalents are sufficient to meet 
our anticipated capital requirements in the next 12 months. Our future capital 
requirements will depend on many factors, including, among other things, our 
growth rate, the timing and extent of our spending to support research and 
development activities, the timing and cost of establishing additional sales 
and marketing capabilities, and the introduction of new products.

Cash Flows

The following table summarizes our cash flows for the periods indicated (in 
thousands):


                                                                              
                                                   Six Months Ended June 30,  
                                                    2024              2023    
                                                        (In thousands)        
Cash provided by operating activities              $     428         $   7,531
Cash used in investing activities                    (1,239)           (1,048)
Cash provided by (used in) financing activities          629           (2,448)


Cash Flows From Operating Activities

During the six months ended June 30, 2024, cash provided by operating 
activities was
$0.4 million
, which consisted of net loss of
$2.7 million
, non-cash charges of
$4.4 million
and changes of net operating assets and liabilities of
$1.2 million
. The non-cash charges consisted of stock-based compensation of
$3.6 million
and depreciation and amortization of
$0.8 million
. The change in our net operating assets and liabilities was primarily due to 
a decrease in accounts receivable of
$1.4 million
due to timing of cash receipts for outstanding balances, a decrease in prepaid 
and other current assets of
$0.5 million
, and a decrease in inventory of
$0.4 million
offset by a decrease in accounts payable of
$0.6 million
, a decrease in accrued liabilities of
$2.6 million
and a decrease in deferred revenue of $
0.3 million
.

During the six months ended June 30, 2023, cash provided by operating 
activities was $7.5 million, which consisted of net income of $4.6 million, 
non-cash charges of $3.2 million and changes of net operating assets and 
liabilities of $0.3 million. The non-cash charges primarily consisted of 
stock-based compensation of $ 2.4 million, depreciation and amortization of 
$0.6 million, and a loss on prepayment and termination of our 2019 Credit 
Facility of $0.2 million.
The
change in our net operating assets and liabilities was primarily due to an 
increase in inventory of $0.7 million, a decrease in accounts payable of $0.7 
million, a decrease in accrued liabilities of $0.7 million primarily due to 
timing of variable compensation costs, and a decrease in deferred revenue of 
$0.1 million, offset by a decrease in accounts receivable of $1.6 million due 
to timing of cash receipts for outstanding balances and a decrease in prepaid 
and other current assets of $0.2 million.

Cash Flows From Investing Activities

Cash used in investing activities during the six months ended June 30, 2024, 
was $1.2 million, reflecting purchases of manufacturing equipment.

Cash used in investing activities during the six months ended June 30, 2023 
was $1.0 million, reflecting $1.1 million for the purchases of manufacturing 
equipment offset by a nominal amount in proceeds received on the sale of 
property and equipment.

Cash Flows From Financing Activities

Cash provided by financing activities during the six months ended June 30, 
2024, was $0.6 million, consisting of proceeds from the exercise of employee 
stock options and purchase of shares under our employee stock purchase plan.

Cash used in financing activities during the six months ended June 30, 2023, 
was $2.5 million, consisting mainly of $2.8 million of payments to pay off our 
2019 Credit Facility, offset by $0.3 million in proceeds from the exercise of 
employee stock options.

                                       22                                       
Table of Contents
Critical Accounting Policies and Significant Judgements and Estimates

Our condensed financial statements have been prepared in accordance with GAAP. 
The preparation of these condensed financial statements requires us to make 
estimates and assumptions that affect the reported amounts of assets and 
liabilities and the disclosure of contingent assets and liabilities at the 
date of the financial statements, as well as the reported revenue generated, 
and expenses incurred during the reporting periods. We base our estimates on 
our historical experience and on various other factors that we believe are 
reasonable under the circumstances, the results of which form the basis for 
making judgments about the carrying value of assets and liabilities that are 
not readily apparent from other sources. Actual results may differ from these 
estimates under different assumptions or conditions.

There have been no changes to our critical accounting policies and estimates 
described in the Annual Report on Form 10-K for the year ended December 31, 
2023, filed with the SEC on February 29, 2024, that have had a material impact 
on our condensed financial statements and related notes.

Item 3. Quantitative and Qualitativ
e Disclosures About Market Risk

Not required for a smaller reporting company.

Item 4. Controls and Procedure
s

Evaluation of disclosure controls and procedures.

Our management, including our Chief Executive Officer (CEO) and Chief 
Financial Officer (CFO), evaluated the effectiveness of the design and 
operation of our disclosure controls and procedures (as defined in Rules 
13a-15(e) and 15d-15(e) under the Exchange Act), as of June 30, 2024, the end 
of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our CEO and CFO concluded that our disclosure 
controls and procedures were effective at the reasonable assurance level as of 
June 30, 2024.

There have been no changes in our internal control over financial reporting 
that occurred during the six months ended June 30, 2024 that materially 
affected, or are reasonably likely to materially affect, our internal control 
over financial reporting.

Inherent limitation on the effectiveness of internal control.
The effectiveness of any system of internal control over financial reporting, 
including ours, is subject to inherent limitations, including the exercise of 
judgment in designing, implementing, operating, and evaluating the controls 
and procedures, and the inability to eliminate misconduct completely. 
Accordingly, any system of internal control over financial reporting, 
including ours, no matter how well designed and operated, can only provide 
reasonable, not absolute assurances. In addition, projections of any 
evaluation of effectiveness to future periods are subject to the risk that 
controls may become inadequate because of changes in conditions, or that the 
degree of compliance with the policies or procedures may deteriorate. We 
intend to continue to monitor and upgrade our internal controls as necessary 
or appropriate for our business, but cannot assure you that such improvements 
will be sufficient to provide us with effective internal control over 
financial reporting.

PART II-O
THER INFORMATIO
N

Item 1. Legal Proceedings

We are not party to any material legal proceedings at this time. From time to 
time, we may become involved in various legal proceedings that arise in the 
ordinary course of our business.

                                       23                                       
Table of Contents
Item 1A. Risk Factors

The following are important factors that could cause actual results or events 
to differ materially from those contained in any forward-looking statements 
made by us or on our behalf. The risks and uncertainties described below are 
not the only ones we face. Additional risks and uncertainties not presently 
known to us or that we deem immaterial also may impair our business 
operations. If any of the following risks or such other risks actually occurs, 
our business, financial condition, results of operations and cash flows could 
be harmed.

Risk Factor Summary

We are subject to a variety of risks and uncertainties, including risks 
related to our financial condition, risks related to our business and our 
industry, risks related to our intellectual property and technology, risks 
related to regulatory matters and compliance, risks related to our common 
stock and certain general risks, which could have a material adverse effect on 
our business, financial condition, results of operations and cash flows. These 
risks include, but are not limited to, the following principal risks:


 We may need additional funding and may be unable to raise capital when needed,
 which could force us to delay, reduce, or eliminate planned activities.       


 We cannot be certain that we will sustain profitability.


 The limited history of STT-MRAM adoption makes it difficult to evaluate our current business and future prospects.


 We may be unable to match production with customer demand for a variety of reasons including
 macroeconomic factors due to the cyclical nature of the semiconductor industry, our         
 inability to accurately forecast customer demand, supply chain constraints, or the          
 capacity constraints of our suppliers, which could adversely affect our operating results.  


 As we expand into new potential markets, we expect to face intense competition, including from our customers
 and potential customers, and may not be able to compete effectively, which could harm our business.         


                                                                                
We rely on third parties to distribute, manufacture, package, assemble and      
test our products, which exposes us to a number of risks, including reduced     
control over manufacturing and delivery timing and potential exposure to price  
fluctuations, which could result in a loss of revenue or reduced profitability. 
                                                                                


 Disruptions in our supply chain and increased cost of components used in our products may adversely impact our
 business, results of operations and financial condition, including our ability to fulfill customer demand.    


 Our joint development agreement and strategic relationships involve numerous risks.


 We must continuously develop new and enhanced products, and if we        
 are unable to successfully market our new and enhanced products for      
 which we incur significant expenses to develop, our results of operations
 and financial condition will be materially adversely affected.           


 Our success and future revenue depend on our ability to secure design wins and on our
 customers' ability to successfully sell the products that incorporate our solutions. 
 Securing design wins is a lengthy, expensive, and competitive process, and may       
 not result in actual orders and sales, which could cause our revenue to decline.     


 The loss of one or several of our customers or reduced orders or pricing from existing  
 customers may have a significant adverse effect on our operations and financial results.


 We face competition and expect competition to increase in the future. If we fail to compete         
 effectively, our revenue growth and results of operations will be materially and adversely affected.


 Our costs may increase substantially if we or our third-party manufacturing
 contractors do not achieve satisfactory product yields or quality.         


                                       24                                       
Table of Contents

 The complexity of our products may lead to defects, which could         
 negatively impact our reputation with customers and result in liability.


 We may experience difficulties in transitioning to new wafer fabrication process technologies or in achieving higher levels  
 of design integration, which may result in reduced manufacturing yields, delays in product deliveries and increased expenses.


 Changes to industry standards and technical requirements relevant to our products and
 markets could adversely affect our business, results of operations, and prospects.   


 Our success depends on our ability to attract and retain key employees, and our failure  
 to do so could harm our ability to grow our business and execute our business strategies.


 We currently maintain, and are seeking to expand, operations outside the United States which exposes us to significant risks.

For a more complete discussion of the material risk factors applicable to us, 
see below.

Risk Factors Related to Our Financial Condition

We may need additional funding and may be unable to raise capital when needed, 
which could force us to delay, reduce, or eliminate planned activities.

Our total revenue was approximately $25.1 million for the six months ended 
June 30, 2024, and $63.8 million for the year ended December 31, 2023. As of 
June 30, 2024, we had cash and cash equivalents of approximately $36.8 
million. Based on our current operating plan, we believe our existing cash and 
cash equivalents, coupled with our anticipated growth and sales levels, will 
be sufficient to meet our anticipated cash requirements for at least the next 
12 months. However, our existing capital may be insufficient to meet our 
long-term requirements. We have no committed sources of funding and there is 
no assurance that additional funding will be available to us in the future or 
be secured on acceptable terms. If adequate funding is not available when 
needed, we may be forced to curtail operations, including our commercial 
activities and research and development programs, or cease operations 
altogether, file for bankruptcy, or undertake any combination of the 
foregoing. In such event, our stockholders may lose their entire investment in 
our company.

Further, we may need to raise additional funds through financings or 
borrowings in order to accomplish our long-term planned objectives. If we 
raise additional funds through issuances of equity, convertible debt 
securities or other securities convertible into equity, our existing 
stockholders could suffer significant dilution in their percentage ownership 
of our company, and any new equity securities we issue could have rights, 
preferences, and privileges senior to those of holders of our common stock.


In addition, if we do not meet our payment obligations to third parties as 
they become due, we may be subject to litigation claims and our creditworthiness
 would be adversely affected. Even if we are successful in defending against 
these claims, litigation could result in substantial costs and would be a 
distraction to management, and may have other unfavorable results that could 
further adversely impact our financial condition. Stockholders should not rely 
on our balance sheet as an indication of the amount of proceeds that would be 
available to satisfy claims of creditors, and potentially be available for 
distribution to stockholders, in the event of liquidation.

We cannot be certain that we will sustain profitability.

While our products offer unique benefits over other industry memory 
technologies, the rate of adoption of our products and our ability to capture 
market share from legacy technologies is uncertain. Our revenue may also be 
adversely impacted by a number of other possible reasons, many of which are 
outside our control, including business conditions that adversely affect the 
semiconductor memory industry resulting in a decline in end market demand for 
our products, adverse impacts resulting from pandemics or endemics, increased 
competition, ongoing supply chain constraints, or our failure to capitalize on 
growth opportunities. We also rely on achieving specific cost reduction 
targets that have uncertainty in their timing and magnitude. We may also incur 
unforeseen expenses in the ongoing operation of our business that cause us to 
exceed our operational spending plan. As a result, our ability to generate 
sufficient revenue growth and/or control expenses to transition to 
profitability and generate consistent positive cash flows is uncertain.

                                       25                                       
Table of Contents
Risk Factors Related to Our Business and Our Industry

The limited history of STT-MRAM adoption makes it difficult to evaluate our 
current business and future prospects.

We have been in existence as a stand-alone company since 2008, when Freescale 
Semiconductor, Inc. (subsequently acquired by NXP Semiconductor) spun-out its 
MRAM business as Everspin. We have been shipping magnetoresistive 
random-access memory (MRAM) products since our incorporation in 2008. However, 
we only began to manufacture and ship our STT-MRAM products in the fourth 
quarter of 2017. We began to manufacture our second set of STT-MRAM products 
targeting the NVSRAM markets in the fourth quarter of 2022.

Our limited experience in selling our STT-MRAM products, combined with the 
rapidly evolving and competitive nature of our markets, makes it difficult to 
evaluate our current business and future prospects. In addition, we have 
limited insight into emerging trends that may adversely affect our business, 
financial condition, results of operations and prospects. We have encountered 
and will continue to encounter risks and difficulties frequently experienced 
by growing companies in rapidly changing industries, including unpredictable 
and volatile revenue and increased expenses as we continue to grow our 
business. The viability and demand for our products may be affected by many 
factors outside of our control, such as the factors affecting the growth of 
the industrial, automotive, transportation, and data center market segments 
and changes in macroeconomic conditions. If we do not manage these risks and 
overcome these difficulties successfully, our business will suffer.

We may be unable to match production with customer demand for a variety of 
reasons including macroeconomic factors due to the cyclical nature of the 
semiconductor industry, our inability to accurately forecast customer demand, 
supply chain constraints, or the capacity constraints of our suppliers, which 
could adversely affect our operating results.

We make planning and spending decisions, including determining production 
levels, production schedules, component procurement commitments, personnel 
needs, and other resource requirements, based on our estimates of product 
demand and customer requirements. Our products are typically purchased 
pursuant to individual purchase orders. While our customers may provide us 
with their demand forecasts, they are not contractually committed to buy any 
quantity of products beyond purchase orders. Furthermore, many of our 
customers may increase, decrease, cancel, or delay purchase orders already in 
place without significant penalty. The short-term nature of commitments by our 
customers and the possibility of unexpected changes in demand for their 
products reduce our ability to accurately estimate future customer 
requirements. On occasion, customers may require rapid increases in 
production, which can strain our resources, necessitate more onerous 
procurement commitments, and reduce our gross margin. If we overestimate 
customer demand, we may purchase products that we may not be able to sell, 
which could result in decreases in our prices or write-downs of unsold 
inventory. Conversely, we could lose sales opportunities and could lose market 
share or damage our customer relationships if, for example, we underestimate 
customer demand, are affected by supply chain constraints, or sufficient 
manufacturing is unavailable. We manufacture MRAM products at our 200mm 
facility we lease in Chandler, Arizona and use a single foundry, GLOBALFOUNDRIES
, for production of higher density products on advanced technology nodes, 
which may not have sufficient capacity to meet customer demand. The rapid pace 
of innovation in our industry could also render significant portions of our 
inventory obsolete. Excess or obsolete inventory levels could result in 
unexpected expenses or write-downs of inventory values that could adversely 
affect our business, operating results, and financial condition.
As we expand into new potential markets, we expect to face intense 
competition, including from our customers and potential customers, and may not 
be able to compete effectively, which could harm our business.
We expect that our new and future MRAM products will be applicable to markets 
in which we are not currently operating. The markets in which we operate and 
may operate in the future are extremely competitive and are characterized by 
rapid technological change, continuous evolving customer requirements and 
declining average selling prices. We may not be able to compete successfully 
against current or potential competitors, which include our current or 
potential customers as they seek to internally develop solutions competitive 
with ours or as we develop products potentially competitive with their 
existing products. If we do not compete successfully, our market share and 
revenue may decline. We compete with large semiconductor manufacturers and 
designers and others, and our current and potential competitors have longer 
operating histories, significantly greater resources and name recognition and 
a larger base of customers than we do. This may allow them to respond more 
quickly than we can to new or emerging
                                       26                                       
Table of Contents
technologies or changes in customer requirements. In addition, these 
competitors may have greater credibility with our existing and potential 
customers. Some of our current and potential customers with their own 
internally developed solutions may choose not to purchase products from 
third-party suppliers like us.
We rely on third parties to distribute, manufacture, package, assemble and 
test our products, which exposes us to a number of risks, including reduced 
control over manufacturing and delivery timing and potential exposure to price 
fluctuations, which could result in a loss of revenue or reduced profitability.


Although we operate an integrated magnetic fabrication line located in 
Chandler, Arizona, we purchase wafers from third parties and outsource the 
manufacturing, packaging, assembly and testing of our products to third-party 
foundries and assembly and testing service providers. We use a single foundry, 
GLOBALFOUNDRIES Singapore Pte. Ltd., for production of higher density products 
on advanced technology nodes. Our primary product package and test operations 
are located in China, Taiwan and other Asian countries. We also use standard 
CMOS wafers from third-party foundries, which we process at our Chandler, 
Arizona facility.

Relying on third-party distribution, manufacturing, assembly, packaging, and 
testing presents a number of risks, including but not limited to:


our interests could diverge from those of our foundries, or we may not be able 
to agree with them on ongoing development, manufacturing and operational 
activities, or on the amount, timing, or nature of further investments in our 
joint development;


capacity and materials shortages during periods of high demand or supply 
constraints;


reduced control over delivery schedules, inventories and quality;


the unavailability of, or potential delays in obtaining access to, key process 
technologies;


the inability to achieve required production or test capacity and acceptable 
yields on a timely basis;


misappropriation of our intellectual property;


the third party's ability to perform its obligations due to bankruptcy or 
other financial constraints;


exclusive representatives for certain customer engagements;


limited warranties on wafers or products supplied to us; and


potential increases in prices including due to inflation.

Our manufacturing agreement with GLOBALFOUNDRIES includes a customary forecast 
and ordering mechanism for the supply of certain of our wafers, and we are 
obligated to order and pay for, and GLOBALFOUNDRIES is obligated to supply, 
wafers consistent with the binding portion of our forecast. However, our 
manufacturing arrangement is also subject to both a minimum and maximum order 
quantity that while we believe currently addresses our projected foundry 
capacity needs, may not address our maximum foundry capacity requirements in 
the future. We may also be obligated to pay for unused capacity if our demand 
decreases in the future, or if our estimates prove inaccurate. GLOBALFOUNDRIES 
also has the ability to discontinue its manufacture of any of our wafers upon 
due notice and completion of the notice period. This could cause us to have to 
find another foundry to manufacture those wafers or redesign our core 
technology and would mean that we may not have products to sell until such 
time. Any time spent engaging a new manufacturer or redesigning our core 
technology could be costly and time consuming and may allow potential 
competitors to take opportunities in the marketplace. Moreover, if we are 
unable to find another foundry to manufacture our products or if we have to 
redesign our core technology, this could cause material harm to our business 
and operating results.

If we need other foundries or packaging, assembly, and testing contractors, or 
if we are unable to obtain timely and adequate deliveries from our providers, 
we might not be able to cost-effectively and quickly retain other vendors to 
satisfy our requirements. Because the lead time needed to establish a 
relationship with a new third-party supplier could
                                       27                                       
Table of Contents
be several quarters, there is no readily available alternative source of 
supply for any specific component. In addition, the time and expense to 
qualify a new foundry could result in additional expense, diversion of 
resources or lost sales, any of which would negatively impact our financial 
results.

If any of our current or future foundries or packaging, assembly and testing 
subcontractors significantly increases the costs of wafers or other materials 
or services, interrupts or reduces our supply, including for reasons outside 
of their control, such as due to pandemics or epidemics, or if any of our 
relationships with our suppliers is terminated, our operating results could be 
adversely affected. Such occurrences could also damage our customer 
relationships, result in lost revenue, cause a loss in market share, or damage 
our reputation.

Disruptions in our supply chain and increased cost of components used in our 
products may adversely impact our business, results of operations and 
financial condition, including our ability to fulfill customer demand.


If we fail to procure sufficient components used in our products, we may be 
unable to deliver our products to our customers on a timely basis, which could 
lead to customer dissatisfaction and could harm our reputation and ability to 
compete. We would likely experience significant delays or cessation in 
producing some of our products if a labor strike, natural disaster, public 
health crisis, geopolitical event, or other supply disruption were to occur, 
including as a result of public health issues, such as pandemics and 
epidemics, or the ongoing military conflict between Russia and Ukraine, at any 
of our main suppliers.
Further, the upturn in the semiconductor industry has stretched the supply 
chain, and we are subject to supply shortages, as well as higher costs as 
suppliers opportunistically raise prices. For example, there is currently a 
worldwide shortage of semiconductor, memory and other electronic components 
affecting many industries. Our products are dependent on some of these 
electronic components. A continued shortage of electronic components may 
impact us significantly and could cause us to experience extended lead times 
and increased prices from our suppliers, which could be significant. Extended 
lead times and decreased availability of key components could result in a 
significant disruption to our production schedule, all of which would have an 
adverse effect on our business, results of operations and financial condition. 
Additionally, the military conflict between Russia and Ukraine creates 
additional uncertainty and risks relating to our supply chain and the cost of 
components. See "-General Risk Factors-Unfavorable economic, market and 
geopolitical conditions, domestically and internationally, may adversely 
affect our business, financial condition, results of operations and cash 
flows" for additional information.
We do not have any guarantees of supply from our third-party suppliers, and in 
certain cases we have limited contractual arrangements or are relying on 
standard purchase orders or on component parts available on the open market, 
which may further result in increased costs combined with reduced 
availability. A continued delay in our ability to produce and deliver our 
products could also cause our customers to purchase alternative products from 
our competitors and/or harm our reputation.

Our joint development agreement and strategic relationships involve numerous 
risks.

We have entered into strategic relationships to manufacture products and 
develop new manufacturing process technologies and products. These 
relationships include our joint development agreement with GLOBALFOUNDRIES to 
develop advanced MTJ technology and STT-MRAM. These relationships are subject 
to various risks that could adversely affect the value of our investments and 
our results of operations. These risks include the following:


our interests could diverge from those of our foundries, or we may not be able 
to agree with them on ongoing development, manufacturing and operational 
activities, or on the amount, timing, or nature of further investments in our 
joint development;


we may experience difficulties in transferring technology to a foundry;


we may experience difficulties and delays in getting to and/or ramping 
production at foundries;


our control over the operations of foundries is limited;


due to financial constraints, our joint development collaborators may be 
unable to meet their commitments to us and may pose credit risks for our 
transactions with them;

                                       28                                       
Table of Contents

due to differing business models or long-term business goals, our 
collaborators may decide not to join us in funding capital investment, which 
may result in higher levels of cash expenditures by us;


our cash flows may be inadequate to fund increased capital requirements;


we may experience difficulties or delays in collecting amounts due to us from 
our collaborators;


the terms of our arrangements may turn out to be unfavorable;


we are migrating toward a fabless model as 300mm production becomes required 
and this increases risks related to less control over our critical production 
processes; and


changes in tax, legal, or regulatory requirements may necessitate changes in 
our agreements.

The term of the agreement, as amended, is the completion, termination, or 
expiration of the last statement of work
entered into pursuant to the joint development agreement.

If our strategic relationships are unsuccessful, our business, results of 
operations, or financial condition may be materially adversely affected.

We must continuously develop new and enhanced products, and if we are unable 
to successfully market our new and enhanced products for which we incur 
significant expenses to develop, our results of operations and financial 
condition will be materially adversely affected.

To compete effectively in our markets, we must continually design, develop, 
and introduce new and improved technology and products with improved features 
in a cost-effective manner in response to changing technologies and market 
demand. This requires us to devote substantial financial and other resources 
to research and development. We are developing new technology and products, 
which we expect to be one of the drivers of our revenue growth in the future. 
We also face the risk that customers may not value or be willing to bear the 
cost of incorporating our new and enhanced products into their products, 
particularly if they believe their customers are satisfied with current 
solutions. Regardless of the improved features or superior performance of our 
new and enhanced products, customers may be unwilling to adopt our solutions 
due to design or pricing constraints, or because they do not want to rely on a 
single or limited supply source. Because of the extensive time and resources 
that we invest in developing new and enhanced products, if we are unable to 
sell customers our new products, our revenue could decline and our business, 
financial condition, results of operations and cash flows would be negatively 
affected. For example, if we are unable to generate more customer adoption of 
our 1Gb product and address new growth opportunities with subsequent STT-MRAM 
products, we may not be able to materially increase our revenue. If we are 
unable to successfully develop and market our new and enhanced products that 
we have incurred significant expenses developing, our results of operations 
and financial condition will be materially and adversely affected.

Our success and future revenue depend on our ability to secure design wins and 
on our customers' ability to successfully sell the products that incorporate 
our solutions. Securing design wins is a lengthy, expensive, and competitive 
process, and may not result in actual orders and sales, which could cause our 
revenue to decline.

We sell to customers, including OEMs and ODMs, that incorporate MRAM into 
their products. A design win occurs after a customer has tested our product, 
verified that it meets the customer's requirements and qualified our solutions 
for their products. We believe we are dependent, among other things, on the 
adoption of our 256Mb and 1Gb MRAM products by our customers to secure design 
wins. Our customers may need several months to years to test, evaluate, and 
adopt our product and additional time to begin volume production of the 
product that incorporates our solution. Due to this generally lengthy design 
cycle, we may experience significant delays from the time we increase our 
operating expenses and make investments in our products to the time that we 
generate revenue from sales of these products. Moreover, even if a customer 
selects our solution, we cannot guarantee that this will result in any sales 
of our products, as the customer may ultimately change or cancel its product 
plans, or efforts by our customer to market and sell its product may not be 
successful. We may not generate any revenue from design wins after incurring 
the associated costs, which would cause our business and operating results to 
suffer.

                                       29                                       
Table of Contents
If a current or prospective customer incorporates a competitor's solution into 
its product, it becomes significantly more difficult for us to sell our 
solutions to that customer because changing suppliers involves significant 
time, cost, effort, and risk for the customer even if our solutions are 
superior to other solutions and remain compatible with their product design. 
Our ability to compete successfully depends on customers viewing us as a 
stable and reliable supplier to mission-critical customer applications when we 
have less production capacity and less financial resources compared to most of 
our larger competitors. If current or prospective customers do not include our 
solutions in their products and we fail to achieve a sufficient number of 
design wins, our results of operations and business may be harmed.

The loss of one or several of our customers or reduced orders or pricing from 
existing customers may have a significant adverse effect on our operations and 
financial results.

We have derived and expect to continue to derive a significant portion of our 
revenues from a small group of customers during any particular period due in 
part to the concentration of market share in the semiconductor industry. Our 
two largest end customers together accounted for 32% of our total revenue for 
the six months ended June 30, 2024, and each of these customers accounted for 
more than 10% of our revenue during that period. Our two largest end customers 
together accounted for 22% of our total revenue for the year ended December 
31, 2023, and one of those customers individually accounted for more than 10% 
of our total revenue during the period. The loss of a significant customer, a 
business combination among our customers, a reduction in orders or decrease in 
price from a significant customer or disruption in any of our commercial or 
distributor arrangements may result in a significant decline in our revenues 
and could have a material adverse effect on our business, liquidity, results 
of operations, financial condition, and cash flows.

We face competition and expect competition to increase in the future. If we 
fail to compete effectively, our revenue growth and results of operations will 
be materially and adversely affected.

The global semiconductor market in general, and the semiconductor memory 
market in particular, are highly competitive. We expect competition to 
increase and intensify as other semiconductor companies enter our markets, 
many of which have greater financial and other resources with which to pursue 
technology development, product design, manufacturing, marketing and sales and 
distribution of their products. Increased competition could result in price 
pressure, reduced revenue, and profitability and loss of market share, any of 
which could materially and adversely affect our business, revenue, and 
operating results. Currently, our competitors range from large, international 
companies offering a wide range of traditional memory technologies to 
companies specializing in other alternative, specialized emerging memory 
technologies. Our primary memory competitors include Fujitsu, Infineon, 
Integrated Silicon Solution, Intel, Macronix, Microchip, Micron, Renesas, 
Samsung, and Toshiba. In addition, as the MRAM market opportunity grows, we 
expect new entrants may enter this market and existing competitors, including 
leading semiconductor companies, may make significant investments to compete 
more effectively against our products. These competitors could develop 
technologies or architectures that make our products or technologies obsolete.


Our ability to compete successfully depends on factors both within and outside 
of our control, including:


the functionality and performance of our products and those of our competitors;


our relationships with our customers and other industry participants;


prices of our products and prices of our competitors' products;


our ability to develop innovative products;


our competitors' greater resources to make acquisitions;


our ability to obtain adequate capital to finance operations;


our ability to retain high-level talent, including our management team and 
engineers; and


the actions of our competitors, including merger and acquisition activity, 
launches of new products and other actions that could change the competitive 
landscape.

                                       30                                       
Table of Contents
In the event of a market downturn, competition in the markets in which we 
operate may intensify as our customers reduce their purchase orders. Our 
competitors that are significantly larger and have greater financial, 
technical, marketing, distribution, customer support and other resources or 
more established market recognition than us may be better positioned to accept 
lower prices and withstand adverse economic or market conditions.

Our costs may increase substantially if we or our third-party manufacturing 
contractors do not achieve satisfactory product yields or quality.

The fabrication process is extremely complicated and small changes in design, 
specifications or materials can result in material decreases in product yields 
or even the suspension of production. From time to time, we and/or the 
third-party foundries that we contract to manufacture our products may 
experience manufacturing defects and reduced manufacturing yields. In some 
cases, we and/or our third-party foundries may not be able to detect these 
defects early in the fabrication process or determine the cause of such 
defects in a timely manner. There may be a higher risk of product yield issues 
in newer STT-MRAM products.

Generally, in pricing our products, we assume that manufacturing yields will 
continue to improve, even as the complexity of our products increases. Once 
our products are initially qualified either internally or with our third-party 
foundries, minimum acceptable yields are established. We are responsible for 
the costs of the units if the actual yield is above the minimum set with our 
third-party foundries. If actual yields are below the minimum, we are not 
required to purchase the units. Typically, minimum acceptable yields for our 
new products are generally lower at first and gradually improve as we achieve 
full production but yield issues can occur even in mature processes due to 
break downs in mechanical systems, equipment failures or calibration errors. 
Unacceptably low product yields or other product manufacturing problems could 
substantially increase overall production time and costs and adversely impact 
our operating results. Product yield losses may also increase our costs and 
reduce our gross margin. In addition to significantly harming our results of 
operations and cash flow, poor yields may delay shipment of our products and 
harm our relationships with existing and potential customers.

The complexity of our products may lead to defects, which could negatively 
impact our reputation with customers and result in liability.

Products as complex as ours may contain defects when first introduced to 
customers or as new versions are released. Delivery of products with 
production defects or reliability, quality or compatibility problems could 
significantly delay or hinder market acceptance of the products or result in a 
costly recall and could damage our reputation and adversely affect our ability 
to retain existing customers and attract new customers. Defects could cause 
problems with the functionality of our products, resulting in interruptions, 
delays, or cessation of sales of these products to our customers. We may also 
be required to make significant expenditures of capital and resources to 
resolve such problems. We cannot assure our stockholders that problems will 
not be found in new products, both before and after commencement of commercial 
production, despite testing by us, our suppliers, or our customers. For 
example, any such problems could result in:


delays in development, manufacture and roll-out of new products;


additional development costs;


loss of, or delays in, market acceptance;


diversion of technical and other resources from our other development efforts;


claims for damages by our customers or others against us; and


loss of credibility with our current and prospective customers.

Any such event could have a material adverse effect on our business, financial 
condition, and results of operations.

We may experience difficulties in transitioning to new wafer fabrication 
process technologies or in achieving higher levels of design integration, 
which may result in reduced manufacturing yields, delays in product deliveries 
and increased expenses.

                                       31                                       
Table of Contents
We aim to use the most advanced manufacturing process technology appropriate 
for our solutions that is available from our third-party foundries. As a 
result, we periodically evaluate the benefits of migrating our solutions to 
other technologies to improve performance and reduce costs. These ongoing 
efforts require us from time to time to modify the manufacturing processes for 
our products and to redesign some products, which in turn may result in delays 
in product deliveries.

For example, as smaller line width geometry manufacturing processes become 
more prevalent, we intend to move our future products to increasingly smaller 
geometries to integrate greater levels of memory capacity and/or functionality 
into our products. This transition will require us and our third-party 
foundries to migrate to new designs and manufacturing processes for smaller 
geometry products.

We may face difficulties, delays, and increased expense as we transition our 
products to new processes, and potentially to new foundries. We will depend on 
our third-party foundries as we transition to new processes. We cannot assure 
our stockholders that our third-party foundries will be able to effectively 
manage such transitions or that we will be able to maintain our relationship 
with our third-party foundries or develop relationships with new third-party 
foundries. If we or any of our third-party foundries experience significant 
delays in transitioning to new processes or fail to efficiently implement 
transitions, we could experience reduced manufacturing yields, delays in 
product deliveries and increased expenses, any of which could harm our 
relationships with our customers and our operating results.

Changes to industry standards and technical requirements relevant to our 
products and markets could adversely affect our business, results of 
operations and prospects.

Our products are only a part of larger electronic systems. All products 
incorporated into these systems must comply with various industry standards 
and technical requirements created by regulatory bodies or industry 
participants to operate efficiently together. Industry standards and technical 
requirements in our markets are evolving and may change significantly over 
time. For our products, the industry standards are developed by the Joint 
Electron Device Engineering Council, an industry trade organization. In 
addition, large industry-leading semiconductor and electronics companies play 
a significant role in developing standards and technical requirements for the 
product ecosystems within which our products can be used. Our customers also 
may design certain specifications and other technical requirements specific to 
their products and solutions. These technical requirements may change as the 
customer introduces new or enhanced products and solutions.

Our ability to compete in the future will depend on our ability to identify 
and comply with evolving industry standards and technical requirements. The 
emergence of new industry standards and technical requirements could render 
our products incompatible with products developed by other suppliers or make 
it difficult for our products to meet the requirements of certain of our 
customers in automotive, transportation, industrial, data storage, and other 
markets. As a result, we could be required to invest significant time and 
effort and to incur significant expense to redesign our products to ensure 
compliance with relevant standards and requirements. If our products are not 
in compliance with prevailing industry standards and technical requirements 
for a significant period of time, we could miss opportunities to achieve 
crucial design wins, our revenue may decline and we may incur significant 
expenses to redesign our products to meet the relevant standards, which could 
adversely affect our business, results of operations and prospects.

Our success depends on our ability to attract and retain key employees, and 
our failure to do so could harm our ability to grow our business and execute 
our business strategies.

Our success depends on our ability to attract and retain our key employees, 
including our management team and experienced engineers. Competition for 
personnel in the semiconductor memory technology field, and in the MRAM space 
in particular, is intense, and the availability of suitable and qualified 
candidates is limited. We compete to attract and retain qualified research and 
development personnel with other semiconductor companies, universities, and 
research institutions. Given our experience as an early entrant in the MRAM 
space, our employees are frequently contacted by MRAM startups and MRAM groups 
within larger companies seeking to employ them. The members of our management 
and our key employees are at-will. If we lose the services of any key senior 
management member or employee, we may not be able to locate suitable or 
qualified replacements, and may incur additional expenses to recruit and train 
new personnel, which could severely impact our business and prospects. The 
loss of the services of one or more of our key employees, especially our key 
engineers, or our inability to attract and retain qualified engineers, could 
harm our business, financial condition, and results of operations.

                                       32                                       
Table of Contents
We currently maintain and are seeking to expand operations outside of the 
United States which exposes us to significant risks.

The success of our business depends, in large part, on our ability to operate 
successfully from geographically disparate locations and to further expand our 
international operations and sales. Operating in international markets
requires significant resources and management attention and subjects us to 
regulatory, economic, and political risks that are different from those we 
face in the United States. We cannot be sure that further international 
expansion will be successful. In addition, we face risks in doing business 
internationally that could expose us to reduced demand for our products, lower 
prices for our products or other adverse effects on our operating results. The 
success and profitability, as well as the expansion, of our international 
operations are subject to numerous risks and uncertainties, many of which are 
outside of our control, such as the following:

public health issues, such as pandemics and epidemics, which can result in 
varying impacts to our business, employees, partners, customers, distributors 
or suppliers internationally as discussed elsewhere in this "Risk Factors" 
section;

difficulties, inefficiencies and costs associated with staffing and managing 
foreign operations;

longer and more difficult customer qualification and credit checks;


greater difficulty collecting accounts receivable and longer payment cycles;

the need for various local approvals to operate in some countries;


difficulties in entering some foreign markets without larger-scale local 
operations;

changes in import/export laws, trade restrictions, regulations and customs and 
duties and tariffs (foreign and domestic);

compliance with local laws and regulations;


unexpected changes in regulatory requirements, including the elimination of 
tax holidays;


reduced protection for intellectual property rights in some countries;

adverse tax consequences as a result of repatriating cash generated from 
foreign operations to the United States;

adverse tax consequences, including potential additional tax exposure if we 
are deemed to have established a permanent establishment outside of the United 
States;

the effectiveness of our policies and procedures designed to ensure compliance 
with the Foreign Corrupt Practices Act of 1977 and similar regulations;

fluctuations in currency exchange rates, which could increase the prices of 
our products to customers outside of the United States, increase the expenses 
of our international operations by reducing the purchasing power of the U.S. 
dollar and expose us to foreign currency exchange rate risk if, in the future, 
we denominate our international sales in currencies other than the U.S. dollar;


new and different sources of competition;


political, economic, and social instability;

terrorism and acts of war, such as ongoing military conflict between Russia 
and Ukraine, which could have a negative impact on the operations of our 
business or the businesses of our customers; and


US Department of Commerce regulations or restrictions on exports of certain 
semiconductor technologies and equipment to China.
                                       33                                       
Table of Contents

Our failure to manage any of these risks successfully could harm our 
operations and reduce our revenue.


Risk Factors Related to Our Intellectual Property and Technology

Failure to protect our intellectual property could substantially harm our 
business.

Our success and ability to compete depend in part upon our ability to protect 
our intellectual property. We rely on a combination of intellectual property 
rights, including patents, mask work protection, copyrights, trademarks, trade 
secrets and know-how, in the United States and other jurisdictions. The steps 
we take to protect our intellectual property rights may not be adequate, 
particularly in foreign jurisdictions such as China. Any patents we hold may 
not adequately protect our intellectual property rights or our products 
against competitors, and third parties may challenge the scope, validity, or 
enforceability of our issued patents, which third parties may have 
significantly more financial resources with which to litigate their claims 
than we have to defend against them. In addition, other parties may 
independently develop similar or competing technologies designed around any 
patents or patent applications that we hold. Some of our products and 
technologies are not covered by any patent or patent application, as we do not 
believe patent protection of these products and technologies is critical to 
our business strategy at this time. A failure to timely seek patent protection 
on products or technologies generally precludes us from seeking future patent 
protection on these products or technologies.

In addition to patents, we also rely on contractual protections with our 
customers, suppliers, distributors, employees, and consultants, and we 
implement security measures designed to protect our trade secrets and 
know-how. However, we cannot assure our stockholders that these contractual 
protections and security measures will not be breached, that we will have 
adequate remedies for any such breach or that our customers, suppliers, 
distributors, employees, or consultants will not assert rights to intellectual 
property or damages arising out of such contracts.

We may initiate claims against third parties to protect our intellectual 
property rights if we are unable to resolve matters satisfactorily through 
negotiation. Litigation brought to protect and enforce our intellectual 
property rights could be costly, time-consuming, and distracting to 
management. It could also result in the impairment or loss of portions of our 
intellectual property, as an adverse decision could limit our ability to 
assert our intellectual property rights, limit the value of our technology or 
otherwise negatively impact our business, financial condition, and results of 
operations. Additionally, any enforcement of our patents or other intellectual 
property may provoke third parties to assert counterclaims against us. Our 
failure to secure, protect and enforce our intellectual property rights could 
materially harm our business.

We may face claims of intellectual property infringement, which could be 
time-consuming, costly to defend or settle, result in the loss of significant 
rights, harm our relationships with our customers and distributors, or 
otherwise materially adversely affect our business, financial condition, and 
results of operations.

The semiconductor memory industry is characterized by companies that hold 
patents and other intellectual property rights and that vigorously pursue, 
protect, and enforce intellectual property rights. These companies include 
patent holding companies or other adverse patent owners who have no relevant 
product revenue and against whom our own patents may provide little or no 
deterrence. From time to time, third parties may assert against us and our 
customers' patent and other intellectual property rights to technologies that 
are important to our business. We have in the past, and may in the future, 
face such claims.

Claims that our products, processes, or technology infringe third-party 
intellectual property rights, regardless of their merit or resolution, could 
be costly to defend or settle and could divert the efforts and attention of 
our management and technical personnel. We may also be obligated to indemnify 
our customers or business partners in connection with any such litigation, 
which could result in increased costs. Infringement claims also could harm our 
relationships with our customers or distributors and might deter future 
customers from doing business with us. If any such proceedings result in an 
adverse outcome, we could be required to:


cease the manufacture, use or sale of the infringing products, processes or 
technology;


pay substantial damages for infringement;

                                       34                                       
Table of Contents

expend significant resources to develop non-infringing products, processes or 
technology, which may not be successful;


license technology from the third-party claiming infringement, which license 
may not be available on commercially reasonable terms, or at all;


cross-license our technology to a competitor to resolve an infringement claim, 
which could weaken our ability to compete with that competitor; or


pay substantial damages to our customers to discontinue their use of or to 
replace infringing technology sold to them with non-infringing technology, if 
available.

Any of the foregoing results could have a material adverse effect on our 
business, financial condition, and results of operations. Furthermore, our 
exposure to the foregoing risks may also be increased if we acquire other 
companies or technologies. For example, we may have a lower level of 
visibility into the development process with respect to intellectual property 
or the care taken to safeguard against infringement risks with respect to the 
acquired company or technology. In addition, third parties may make 
infringement and similar or related claims after we have acquired technology 
that had not been asserted prior to the acquisition.

We make significant investments in new technologies and products that may not 
achieve technological feasibility or profitability or that may limit our 
revenue growth.

We have made and will continue to make significant investments in research and 
development of new technologies and products, including new and more 
technically advanced versions of our MRAM technology.

Investments in new technologies are speculative and technological feasibility 
may not be achieved. Commercial success depends on many factors including 
demand for innovative technology, availability of materials and equipment, 
selling price the market is willing to bear, competition and effective 
licensing or product sales. We may not achieve significant revenue from new 
product investments for a number of years, if at all. Moreover, new 
technologies and products may not be profitable, and even if they are 
profitable, operating margins for new products and businesses may not be as 
high as the margins we have experienced historically or originally 
anticipated. Our inability to capitalize on or realize substantial revenue 
from our significant investments in research and development could harm our 
operating results and distract management, harming our business.

Interruptions in or other compromises of our information technology systems or 
data or that of third parties upon whom we rely could adversely affect our 
business.

We rely on the efficient, uninterrupted and uncompromised operation of complex 
information technology systems and networks (and those of third parties) to 
operate our business. Any significant disruption to or other compromise of our 
systems, networks or data (or those of third parties upon whom we rely), 
including, but not limited to, due to new system implementations, computer 
viruses, social-engineering attacks, personnel (including former personnel) 
misconduct or error, supply-chain attacks, ransomware attacks, software bugs, 
software or hardware failure, security breaches, facility issues, natural 
disasters, terrorism, war, telecommunication failures, energy blackouts, loss, 
theft or similar threats, could have a material adverse impact on our 
operations, sales, and financial results. Such disruption or other compromise 
could result in a loss of our intellectual property or the release of 
sensitive competitive information or supplier, customer, personnel or other 
relevant stakeholder's personal data. Additionally, future or past business 
transactions (such as acquisitions or integrations) could expose us to 
additional cybersecurity risks and vulnerabilities, as our systems could be 
negatively affected by vulnerabilities present in acquired or integrated 
entities' systems and technologies. Furthermore, we may discover security 
issues that were not found during due diligence of such acquired or integrated 
entities, and it may be difficult to integrate companies into our information 
technology environment and security program. Any loss of such information 
could harm our competitive position, result in a loss of customer confidence, 
result in breaches of applicable obligations (such as laws and contracts) and 
cause us to incur significant costs to remedy the damages caused by any such 
disruptions or security breaches. Additionally, any failure to properly manage 
the collection, handling, transfer, or disposal of personal data of employees 
and customers may result in regulatory penalties, bans on processing personal 
data or orders not to use or destroy data, enforcement actions, remediation 
obligations, litigation, fines, and other actions.

                                       35                                       
Table of Contents
We may experience attacks on our data and/or information systems, attempts to 
breach our security and attempts to introduce malicious software into our IT 
systems. Such threats are prevalent and continue to rise, are increasingly 
difficult to detect, and come from a variety of sources. During times of war 
and other major conflicts, we and the third parties upon which we rely may be 
vulnerable to a heightened risk of these attacks. If attacks are successful, 
we may be unaware of the incident, its magnitude, or its effects until 
significant harm is done. Any such attack or disruption could result in 
additional costs related to rebuilding of our internal systems, defending 
litigation, responding to regulatory actions, or paying damages. Such attacks 
or disruptions could have a material adverse impact on our business, 
operations, and financial results. Attempts to gain unauthorized access to our 
IT systems or other attacks have in the past, in certain instances and to 
certain degrees, been successful (but have not caused significant harm), and 
may in the future be successful, and in some cases, we might be unaware of an 
incident or its magnitude and effects.

Third-party service providers, such as wafer foundries, assembly and test 
contractors, distributors and other vendors have access to certain portions of 
our and our customers' sensitive data. Our ability to monitor these third 
parties' information security practices is limited, and these third parties 
may not have adequate information security measures in place. In the event 
that these service providers do not properly safeguard the data that they 
hold, security breaches and loss of data could result. Any such loss of data 
by our third-party service providers could negatively impact our business, 
operations, and financial results, as well as our relationship with our 
customers.

While we have implemented security measures designed to protect against 
security incidents, there can be no assurance that these measures will be 
effective. We take steps designed to detect, mitigate, and remediate 
vulnerabilities in our information systems (such as our hardware and/or 
software, including that of third parties upon which we rely). We may not, 
however, detect and remediate all such vulnerabilities including on a timely 
and effective basis. Further, we may experience delays in developing and 
deploying remedial measures and patches designed to address identified 
vulnerabilities. Vulnerabilities could be exploited and result in a security 
incident.

We may expend significant resources or modify our business activities to try 
to protect against security incidents. Additionally, certain data privacy and 
security obligations may require us to implement and maintain specific 
security measures or industry-standard or reasonable security measures to 
protect our information technology systems and sensitive data.

Risk Factors Related to Regulatory Matters and Compliance

To comply with environmental laws and regulations, we may need to modify our 
activities or incur substantial costs, and if we fail to comply with 
environmental regulations, we could be subject to substantial fines or be 
required to have our suppliers alter their processes.

The semiconductor memory industry is subject to a variety of international, 
federal, state, and local governmental regulations directed at preventing or 
mitigating environmental harm, as well as to the storage, discharge, handling, 
generation, disposal and labeling of toxic or other hazardous substances. 
Failure to comply with environmental regulations could subject us to civil or 
criminal sanctions and property damage or personal injury claims. Compliance 
with current or future environmental laws and regulations could restrict our 
ability to expand our business or require us to modify processes or incur 
other substantial expenses which could harm our business. In response to 
environmental concerns, some customers and government agencies impose 
requirements for the elimination of hazardous substances, such as lead (which 
is widely used in soldering connections in the process of semiconductor 
packaging and assembly), from electronic equipment. For example, the European 
Union adopted its Restriction on Hazardous Substance Directive which 
prohibits, with specified exceptions, the sale in the EU market of new 
electrical and electronic equipment containing more than agreed levels of lead 
or other hazardous materials and China has enacted similar regulations. 
Environmental laws and regulations such as these could become more stringent 
over time, causing a need to redesign technologies, imposing greater 
compliance costs, and increasing risks and penalties associated with 
violations, which could seriously harm our business.

Increasing public attention has been focused on the environmental impact of 
electronic manufacturing operations. While we have not experienced any 
materially adverse effects on our operations from recently adopted 
environmental regulations, our business and results of operations could suffer 
if for any reason we fail to control the storage or use of, or to adequately 
restrict the discharge or disposal of, hazardous substances under present or 
future environmental regulations.

                                       36                                       
Table of Contents
Regulations related to "conflict minerals" may force us to incur additional 
expenses, may make our supply chain more complex and may result in damage to 
our reputation with customers.

Pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act, the 
SEC has adopted requirements for companies that use certain minerals and 
metals, known as conflict minerals, in their products, whether or not these 
products are manufactured by third parties. These requirements require 
companies to perform diligence and disclose and report whether or not such 
minerals originate from the Democratic Republic of Congo and adjoining 
countries. These requirements could adversely affect the sourcing, 
availability and pricing of minerals used in the manufacture of our products, 
and affect our costs and relationships with customers, distributors, and 
suppliers as we must obtain additional information from them to ensure our 
compliance with the disclosure requirement. In addition, we incur additional 
costs in complying with the disclosure requirements, including costs related 
to determining the source of any of the relevant minerals and metals used in 
our products. Since our supply chain is complex, we have not been able to 
sufficiently verify the origins for these minerals and metals used in our 
products through the due diligence procedures that we implement, which may 
harm our reputation. In such event, we may also face difficulties in 
satisfying customers who require that all of the components of our products 
are certified as conflict mineral free and these customers may discontinue, or 
materially reduce, purchases of our products, which could result in a material 
adverse effect on our results of operations and our financial condition may be 
adversely affected.

Our ability to use net operating losses to offset future taxable income may be 
subject to certain limitations.

In general, under Section 382 of the U.S. Internal Revenue Code of 1986, as 
amended, or the Code, a corporation that undergoes an "ownership change" is 
subject to limitations on its ability to utilize its pre-change net operating 
losses, or NOLs, to offset future taxable income and tax credits to offset 
tax. As of December 31, 2023, we had gross federal net operating loss 
carryforwards of approximately $96.2 million, of which $55.8 million will 
expire in 2028 through 2037 if not utilized, and $40.5 million will carryover 
indefinitely. As of December 31, 2023, we had state net operating loss 
carryforwards of approximately $48.7 million, of which $45.9 million will 
expire in 2028 through 2043 if not utilized, and $2.8 million will carryover 
indefinitely. The federal NOLs generated prior to 2018 will continue to be 
governed by the NOL tax rules as they existed prior to the adoption of the 
2017 Tax
Cuts and Jobs Act (2017 Tax Act)
, which means that generally they will expire 20 years after they were 
generated if not used prior thereto. The 2017 Tax Act repealed the 20-year 
carryforward and two-year carryback of NOLs originating after December 31, 
2017, and also limits the NOL deduction to 80% of taxable income for tax years 
beginning after December 31, 2017. Any NOLs generated in 2018 and forward will 
be carried forward and will not expire. There is no current impact to us as 
the NOLs that we are utilizing in the current year were generated prior to 
2018, and therefore, are not subject to the 80% limitation. Future changes in 
our stock ownership, many of which are outside of our control, could result in 
an ownership change under Section 382 of the Code. The ability to utilize our 
net operating losses and tax credits could also be impaired under state law. 
As a result, we might not be able to utilize a material portion of our state 
NOLs and tax credits.

Risks Related to Our Common Stock

We expect that the price of our common stock will fluctuate substantially.

The market price of our common stock is likely to be highly volatile and may 
fluctuate substantially due to many factors, including:


the introduction of new products or product enhancements by us or others in 
our industry;


announcements by us or our competitors of significant acquisitions, strategic 
partnerships, joint ventures, capital commitments or restructurings;


disputes or other developments with respect to our or others' intellectual 
property rights;


product liability claims or other litigation;


quarterly variations in our results of operations or those of others in our 
industry;


sales of large blocks of our common stock, including sales by our executive 
officers and directors;

                                       37                                       
Table of Contents

changes in senior management or key personnel;


changes in earnings estimates or recommendations by securities analysts; and


general market conditions and other factors, including factors unrelated to 
our operating performance or the operating performance of our competitors, 
including the effects of pandemics and epidemics and ongoing military conflict 
between Russia and Ukraine.

Stock markets generally have experienced extreme price and volume fluctuations 
that have often been unrelated or disproportionate to the operating 
performance of those companies. Further, the semiconductor memory industry is 
highly cyclical, and our markets may experience significant cyclical 
fluctuations in demand as a result of changing economic conditions, budgeting 
and buying patterns of customers and other factors. Fluctuations in our 
revenue and operating results could also cause our stock price to decline.


In addition, in the past, class action litigation has often been instituted 
against companies whose securities have experienced periods of volatility in 
market price, or for other reasons. Securities litigation brought against us 
following volatility in our stock price or otherwise, regardless of the merit 
or ultimate results of such litigation, could result in substantial costs, 
which would hurt our financial condition and operating results and divert 
management's attention and resources from our business.

These and other factors may make the price of our stock volatile and subject 
to unexpected fluctuation.

Provisions in our corporate charter documents and under Delaware law could 
make an acquisition of us more difficult and may prevent attempts by our 
stockholders to replace or remove our current management.

Provisions in our amended and restated certificate of incorporation and our 
amended and restated bylaws may discourage, delay, or prevent a merger, 
acquisition, or other change in control of us that stockholders may consider 
favorable, including transactions in which stockholders might otherwise 
receive a premium for their shares. These provisions could also limit the 
price that investors might be willing to pay in the future for shares of our 
common stock, thereby depressing the market price of our common stock. In 
addition, these provisions may frustrate or prevent any attempts by our 
stockholders to replace or remove our current management by making it more 
difficult for stockholders to replace members of our board of directors. 
Because our board of directors is responsible for appointing the members of 
our management team, these provisions could in turn affect any attempt by our 
stockholders to replace current members of our management team. Among others, 
these provisions include that:


our board of directors has the right to expand the size of our board of 
directors and to elect directors to fill a vacancy created by the expansion of 
the board of directors or the resignation, death or removal of a director, 
which prevents stockholders from being able to fill vacancies on our board of 
directors;


our stockholders may not act by written consent or call special stockholders' 
meetings; as a result, a holder, or holders, controlling a majority of our 
capital stock would not be able to take certain actions other than at annual 
stockholders' meetings or special stockholders' meetings called by the board 
of directors pursuant to a resolution adopted by a majority of the total 
number of authorized directors, the chairman of the board or the chief 
executive officer;


our amended and restated certificate of incorporation prohibits cumulative 
voting in the election of directors, which limits the ability of minority 
stockholders to elect director candidates;


the affirmative vote of holders of at least 66-2/3% of the voting power of all 
of the then outstanding shares of voting stock, voting as a single class, will 
be required (a) to amend certain provisions of our certificate of 
incorporation, including provisions relating to the size of the board, special 
meetings, actions by written consent and cumulative voting and (b) to amend or 
repeal our amended and restated bylaws, although such bylaws may be amended by 
a simple majority vote of our board of directors;


stockholders must provide advance notice and additional disclosures to 
nominate individuals for election to the board of directors or to propose 
matters that can be acted upon at a stockholders' meeting, which may discourage

                                       38                                       
Table of Contents
or deter a potential acquiror from conducting a solicitation of proxies to 
elect the acquiror's own slate of directors or otherwise attempting to obtain 
control of our company; and


our board of directors may issue, without stockholder approval, shares of 
undesignated preferred stock; the ability to issue undesignated preferred 
stock makes it possible for our board of directors to issue preferred stock 
with voting or other rights or preferences that could impede the success of 
any attempt to acquire us.

Moreover, because we are incorporated in Delaware, we are governed by the 
provisions of Section 203 of the Delaware General Corporation Law, which 
prohibits a person who owns in excess of 15% of our outstanding voting stock 
from merging or combining with us for a period of three years after the date 
of the transaction in which the person acquired in excess of 15% of our 
outstanding voting stock, unless the merger or combination is approved in a 
prescribed manner.

Our amended and restated certificate of incorporation provides that the Court 
of Chancery of the State of Delaware and the federal district courts of the 
United States of America will be the exclusive forums for substantially all 
disputes between us and our stockholders, which could limit our stockholders' 
ability to obtain a favorable judicial forum for disputes with us or our 
directors, officers, or employees.

Our amended and restated certificate of incorporation provides that the Court 
of Chancery of the State of Delaware is the exclusive forum for the following 
types of actions or proceedings under Delaware statutory or common law:

any derivative action or proceeding brought on our behalf;

any action asserting a claim of breach of a fiduciary duty owed by any 
director, officer or other employee to us or our stockholders;

any action asserting a claim against us arising under the Delaware General 
Corporation Law, our amended and restated certificate of incorporation or our 
amended and restated bylaws; and

any action asserting a claim against us that is governed by the internal-affairs
 doctrine.

This provision would not apply to suits brought to enforce a duty or liability 
created by the Exchange Act. Furthermore, Section 22 of the Securities Act 
creates concurrent jurisdiction for federal and state courts over all such 
Securities Act actions. Accordingly, both state and federal courts have 
jurisdiction to entertain such claims. To prevent having to litigate claims in 
multiple jurisdictions and the threat of inconsistent or contrary rulings by 
different courts, among other considerations, our amended and restated 
certificate of incorporation provides
that, unless we consent in writing to the selection of an alternative forum, 
the federal district courts of the United States will be the exclusive forum 
for resolving any complaint asserting a cause of action arising under the 
Securities Act. While the Delaware courts have determined that such choice of 
forum provisions are facially valid, a stockholder may nevertheless seek to 
bring a claim in a venue other than those designated in the exclusive forum 
provisions. In such instance, we would expect to vigorously assert the 
validity and enforceability of the exclusive forum provisions of our amended 
and restated certificate of incorporation. This may require significant 
additional costs associated with resolving such action in other jurisdictions 
and there can be no assurance that the provisions will be enforced by a court 
in those other jurisdictions.

These exclusive forum provisions may limit a stockholder's ability to bring a 
claim in a judicial forum that it finds favorable for disputes with us or our 
directors, officers, or other employees, which may discourage lawsuits against 
us and our directors, officers, and other employees. If a court were to find 
either exclusive-forum provision in our amended and restated certificate of 
incorporation to be inapplicable or unenforceable in an action, we may incur

further significant
additional costs associated with resolving the dispute in other jurisdictions,
all of
which could seriously harm our business.

General Risk Factors

Unfavorable economic and market conditions, domestically and internationally, 
may adversely affect our business, financial condition, results of operations 
and cash flows.

We have significant customer sales both in the United States and internationally
. We also rely on domestic and international suppliers, manufacturing partners 
and distributors. We are therefore susceptible to adverse U.S. and 
international economic and market conditions. If any of our manufacturing 
partners, customers, distributors or suppliers experience slowdowns in their 
business, serious financial difficulties or cease operations, our business 
will be adversely affected. In addition, the adverse impact of general 
economic factors that are beyond our control, including, but not
                                       39                                       
Table of Contents
limited to, housing markets, recession, inflation, deflation, consumer credit 
activity, consumer debt levels, exchange rate volatility, fuel and energy 
costs, interest rates, bank failures, tax rates and policy, unemployment 
trends, potential industry downturn, the impact of natural disasters such as 
pandemics, civil disturbances, terrorist activities and acts of war, including 
ongoing military conflict between Russia and Ukraine, may adversely impact 
consumer spending, which may adversely impact our customers' spending and 
demand for our products. As an example, in the United States, capital markets 
have experienced and continue to experience volatility and disruption. 
Furthermore, inflation rates in the United States have recently increased to 
levels not seen in decades resulting in federal action to increase interest 
rates, affecting capital markets. In addition to the foregoing, adverse 
developments that affect financial institutions, transactional counterparties 
or other third parties, such as bank failures, or concerns or speculation 
about any similar events or risks, could lead to market-wide liquidity 
problems, which in turn may cause third parties, including customers, to 
become unable to meet their obligations under various types of financial 
arrangements as well as general disruptions or instability in the financial 
markets. Additionally, the military conflict in Ukraine and escalating 
geopolitical tensions resulting from such conflict have resulted and may 
continue to result in sanctions, tariffs, and import-export restrictions 
which, when combined with retaliatory actions taken by Russia, could cause 
further inflationary pressures and economic and supply chain disruptions, as 
well as cause us to experience extended lead times and increased prices from 
our suppliers. Any of the foregoing could adversely affect our business, 
financial condition, results of operations and cash flows.

Our business may be adversely impacted by natural disasters and other 
catastrophic events.

Our operations and business, and those of our manufacturing partners, 
customers, distributors, or suppliers, can be disrupted by natural disasters; 
industrial accidents; public health issues, such as pandemics and epidemics; 
cybersecurity incidents; interruptions of service from utilities, 
transportation, telecommunications, or IT systems providers; manufacturing 
equipment failures; or other catastrophic events. For example, some of our 
foundries and suppliers' facilities in Asia are located near known earthquake 
fault zones and, therefore, are vulnerable to damage from earthquakes. We are 
also vulnerable to damage from other types of disasters, such as power loss, 
fire, floods, and similar events. If any such natural disasters or other 
catastrophic events were to occur, our ability to operate our business could 
be seriously impaired. In addition, we may not have adequate insurance to 
cover our losses resulting from disasters or other similar significant 
business interruptions. Any significant losses that are not recoverable under 
our insurance policies could seriously impair our business and financial 
condition.

Item 2. Unregistered Sales of Equity Securitie
s and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Trading Arrangements of Directors and Executive Officers.

None of our directors or executive officers
adopted
, modified, or
terminated
a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as 
defined under Item 408(a) of Regulation S-K) during the quarter ended June 30, 
2024.

                                       40                                       
Table of Contents
Item 6. Exhibit
s

                                  EXHIBIT INDE                                  
                                       X                                        


                                        Incorporation By Reference                                                              
 Exhibit                         Description                              Form      SEC File No.  Exhibit/ Filing Date
 Number                                                                                          Reference            
3.1      Amended and Restated                                              8-K       001-37900      3.1     10/13/2016
         Certificate of                                                                                               
         Incorporation                                                                                                
                                                                                                                                    
3.1.1                                                                 A                             8-K                001-37900  3.
                                                                      mendment                                                      
                                                                      to Amended                                                    
                                                                      and Restated                                                  
                                                                      Certificate                                                   
                                                                      of                                                            
                                                                      Incorporation                                                 
                                                                                                                                    
3.1.2    Amendment to Amended                                              8-K       001-37900      3.1     5/27/2020 
         and Restated                                                                                                 
         Certificate of                                                                                               
         Incorporation                                                                                                
                                                                                                                                    
3.1.3                                                                 Amendment                     8-K                001-37900  3.
                                                                      to Amended                                                    
                                                                      and Restated                                                  
                                                                      Certificate                                                   
                                                                      of                                                            
                                                                      Incorporation                                                 
                                                                                                                                    
3.2                                                                   Amended and                   8-K                001-37900  3.
                                                                      Restated                                                      
                                                                      Bylaws                                                        
                                                                                                                                    
31.1*    Certification                                                                                                              
         of Principal                                                                                                               
         Executive                                                                                                                  
         Officer                                                                                                                    
         Pursuant                                                                                                                   
         to Rules                                                                                                                   
         13a-14(a)                                                                                                                  
         and 15d-14(a)                                                                                                              
         under the                                                                                                                  
         Exchange Act                                                                                                               
                                                                                                                                    
31.2*    Certification of Principal Financial Officer Pursuant       
         to Rules 13a-14(a) and 15d-14(a) under the Exchange Act     
                                                                                                                                    
32.1**   Certification of Principal Executive Officer                
         and Principal Financial Officer Pursuant to 18              
         U.S.C. Section 1350, as Adopted Pursuant to                 
         Section 906 of the Sarbanes-Oxley Act of 2002               
                                                                                                                                    
101.INS* Inline XBRL Instance Document - the instance                
         document does not appear in the Interactive                 
         Data File because its XBRL tags are                         
         embedded within the Inline XBRL document                    
                                                                                                                                    
101.SCH* Inline XBRL Taxonomy Extension Schema Document              
                                                                                                                                    
101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document
                                                                                                                                    
101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 

                                       41                                       
Table of Contents

                                                                                                                           
101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document       
                                                                                                                           
101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document
                                                                                                                           
104*                                                                   Cover Page Interactive Data File (formatted         
                                                                       as Inline XBRL and contained in Exhibit 101)        
                                                                                                                           

*     Filed herewith.
**   Furnished herewith. Exhibit 32.1 is being furnished and shall not be 
deemed to be "filed" for purposes of Section 18 of the Exchange Act, or 
otherwise subject to the liability of that section, nor shall such exhibit be 
deemed to be incorporated by reference in any registration statement or other 
document filed under the Securities Act or the Exchange Act, except as 
otherwise specifically stated in such filing.

                                       42                                       
Table of Contents
                                   SIGNATURE                                    
                                       S                                        
                                                                                
Pursuant to the requirements of the Securities Exchange Act of 1934, the 
registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.


                                                                     
                     Everspin Technologies, Inc.                     
                                                                     
Date: August 2, 2024 By: /s/ Sanjeev Aggarwal                        
                         Sanjeev Aggarwal                            
                         Chief Executive Officer                     
                         (Principal Executive Officer)               
                                                                     
                                                                     
                                                                     
Date: August 2, 2024 By: /s/ Matthew Tenorio                         
                         Matthew Tenorio                             
                         Interim Chief Financial Officer             
                         (Principal Financial and Accounting Officer)



                                       43                                       
{graphic omitted}
{graphic omitted}